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Effects of Peripheral Cooling on Substrate Selection During Exercise 
Director: Brent C. Ruby, Ph.l
Previous research has demonstrated that exercise in the heat significantly increases the 
rate o f muscle glycogenolysis compared to exercise under normal ambient temperatures. 
Purpose: To examine the effects of peripheral cooling via the RTX cooling device 
(Avacore Technologies Inc.) on whole body substrate oxidation during submaximal 
exercise at a moderate ambient temperature (28°C). Methods: Subjects included 
recreationally active college aged males (N=16). Each subject performed an initial cycle 
ergometer VT/V02 max test. Subjects completed two 45-minute cycle ergometer trials 
at a work rate equivalent to approximately 90% VT, one with cooling from the RTX 
cooling device (manifold T= 22°C, P=635mmHg) and one without. Rectal temperature 
was continuously recorded throughout both trials. Trials were performed in a random, 
crossover design. Dependent variables were analyzed using pre-planned comparisons. 
Statistical significance was established at p<0.05. Results: Both groups maintained 
constant carbohydrate use during the cooling trial, whereas without cooling carbohydrate 
use was greater at the beginning of exercise (p<0.05) and decreased with time (p<0.05). 
Fat use increased with time in both trials for both groups. There was no difference in 
rectal temperature between trials. Conclusion: Despite a similar response in rectal 
temperature across trials, peripheral cooling with the AVAcore RTX cooling device 
altered substrate use during submaximal exercise without any difference in total energy 
expenditure.
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Chapter One: Introduction
It is widely recognized that an augmented rise in body temperature during 
submaximal exercise will increase carbohydrate and more specifically glycogen 
utilization during exercise Previous research has shown that an attenuated rise in 
body temperature either by reducing ambient temperatures or by cooling will
reduce glycogen flux and ultimately total carbohydrate oxidation.
Heat stress also influences lipid mobilization and oxidation. Plasma free fatty 
acid levels are unaltered by exercise and heat stress However, it has been shown that 
intramuscular triacylglycerol utilization  ̂and free fatty uptake  ̂* are reduced with 
thermal stress, possibly suggesting that free fatty acid release by adipocytes may be 
reduced during the combination of heat stress and exercise Brooks et al. ' research 
indicates that elevated temperature decreases phosphorylative efficiency in isolated 
skeletal muscle mitochondria also causing an increased reliance on carbohydrate as the 
primary substrate. Febbraio  ̂suggests that elevated muscle temperature may impair 
mitochondrial function. Of note, findings by Mills et al. observed an increase of lipid 
peroxides, an indicator o f oxidative stress, in the plasma o f hyperthermic horses 
exercising to fatigue, possibly supporting the notion that heat stress may cause metabolic 
dysfunction.
Studies have examined RER rate o f glucose disposal (glucose Rd) 
carbohydrate oxidation and muscle glycogen depletion to point toward the use of 
carbohydrates during heat stress. It has been shown that heat stress stimulates an increase 
in hepatic glucose production without an augmented glucose disappearance rate 
Febbraio  ̂suggests that an increase in body temperature and perceived effort promote a
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feed-forward effect resulting in increased blood catecholamines which in return increases 
glycogen utilization in contracting skeletal muscle. Assuming non-protein use, past 
research has shown that RER is increased with heat stress Augmented glycogen
utilization during heat stress was first reported by Fink et al. while comparing exercise 
in 40”C with 9°C. Fink also noted a shift in RER and reduced intramuscular triglyceride 
use indicating increased carbohydrate utilization. Using water-perfused cuffs to cool one 
thigh and heat the other during submaximal exercise, Starkie et al. found that muscle 
glycogen levels were lower in the heated leg compared with the cool leg.
Studies have consistently shown that enhanced heat stress increases blood lactate 
accumulation during exercise Hargreaves et al. suggests than an increased
blood lactate is associated with increased rate of intramuscular glycogen utilization, since 
blood glucose uptake is reduced with heat, yet total carbohydrate oxidation is increased.
In regards to body composition and substrate oxidation, previous findings from 
our lab indicate that high fit (ventilatory threshold >30 ml/kg/min), low fat (10.5±2.3%) 
individuals are better able to maintain lipid metabolism during increased relative 
intensities compared with low fit (ventilatory threshold <20 ml/kg/min), high fat mass 
(27.1±5%) individuals Although explanations for these findings are unknown, the 
thermal control in low fat individuals may, in part explain the observed increase in lipid 
oxidation.
For cooling purposes this study will use an AVAcore (AVAcore Technologies 
Inc.) hand device designed to manipulate core temperature. Built to enhance heat 
extraction by amplifying blood flow to the hand via negative pressure within the capsule, 
the device will influence blood temperature in the hand through contact with a metal plate
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
cooled by 22"C water flow. To our knowledge, no studies have been performed that 
examine the effects o f thermoregulation on substrate utilization, while cooling with a 
temperature <10"C different from the ambient exercise temperature.
Problem
The purpose of this study will be to examine the effects o f peripheral cooling at 
28°C ambient temperature on substrate utilization at 90% ventilatory threshold using a 
hand device developed by AVAcore Technologies. The secondary purpose of this study 
was to examine the substrate selection response between body compositions to the 
peripheral cooling.
Hypothesis One
Peripheral cooling with the hand device will attenuate the rise in core body 
temperature sufficient to attenuate the reliance on carbohydrates and glycogen stores.
Justification o f  Hypothesis One
Febbraio states that a >.5 degree Celsius difference in body temperature will alter 
substrate selection Young et al. and Febbraio et al.  ̂suggest that increased 
temperature will cause a shift in enzyme action, primarily phosphofhictokinase, glycogen 
phosphorylase, and pyruvate kinase, due to the Q-10 effect thus shifting substrate use 
towards increased carbohydrate utilization and a reduced lipid oxidation. The cooling 
device from AVAcore Technology has a negative pressure inside the capsule so when the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
hand is placed within it continually circulates superficial blood flow through the hand. 
Water cooled to 22“C flows through the capsule floor allowing blood to be cooled 
without stimulating vasoconstriction. Previous findings from our lab found that cooling 
using the hand device altered substrate selection in submaximal exercise in a 100"F 
environment.
Hypothesis two
Subjects with greater than eighteen percent fat mass will have a lower fat 
oxidation at a given time during exercise than those with less than ten percent fat mass.
Justification o f  Hypothesis Two
Recent findings from our lab indicate that high fat, low fit individuals had 
similar fat oxidation at 70% of ventilatory threshold (VT) to those with low fat, high 
fitness levels. However at 85% and 100% of VT, high fat, low fit individuals had 
significantly less fat oxidation than those with low fat, high fitness levels.
Significance of the study
Research has shown that attenuated rise in body temperature either by reducing 
ambient temperature ® or by cooling will reduce glycogenolic rate and carbohydrate 
oxidation. Sparing glycogen stores and increasing lipid metabolism can benefit 
performance during exercise. Previous research has used extreme temperature difference 
or radical cooling and heat temperatures to alter substrate selection; our study will
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
use a cooling temperature 6°C lower than ambient to examine if  even minute differences 
in temperature will make significant differences in substrate selection. Our study will 
also compare differences in substrate use between body compositions.
Rational of the study
Previous attempts to regulate core temperature have been done using methods 
such as ice packs lowering ambient temperature  ̂or direct cooling of working 
muscle Our study will examine the effects o f peripheral cooling using an AVAcore 
hand device. We will also examine the efficacy of the AVAcore device to alter substrate 
use between body compositions. Future use from results of this study may include 
thermoregulation attempts in athletics to retain glycogen stores or health industry to 
enhance lipid oxidation duration.
Limitations
i/ Physical capacity of the subjects: The subjects will have differing fitness levels and 
physical capacities. To correct for this, all subjects will work at a relative intensity.
ii/ Non-randomized samples: The subjects will not be randomly selected. The subjects 
will be acquired on a volunteer basis.
iii/ Instrumentation: There is inherent error with all instrumentation. Using trained 
testers and calibrated equipment will minimize this error.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
iv/ Body Temperature: Beginning core temperatures cannot be controlled.
Delimitations
i/ Body Composition: Subjects will have either <10% fat mass or >18% fat mass.
ii/ Age of subjects: Only college males will be used in this study. Aging has been shown 
to influence substrate use during exercise Therefore, in this study only college-aged 
subjects will be used.
iii/ Gender: Hormone differences between genders have been shown to alter substrate 
use In this study only males will be used to eliminate differences between genders.
iv/ Temperature: Room temperature will be maintained at 28®C.
Definition of Terms
Relative intensity: Intensity relative to a specific level of stress.
Respiratory Exchange Ratio (RER): The ratio of VCO2 expired to VO2 consumed. RER 
is used to indicate the primary substrates being used. Since fat metabolism requires more 
oxygen, a lower RER indicates increased fat oxidation. Theoretically, an RER of 1.0 is 
indicative of 100% carbohydrate oxidation and an RER of .71 is indicative of 100% fat 
oxidation.
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Substrate: A  selected fuel utilized to produce energy.
VCO2 : The amount o f carbon dioxide produced/minute; generally expressed as L/min. 
VO2 ' The amount of oxygen utilized by the body/min; generally expressed as L/min. 
Thermoregulation: Regulation of deep body temperature.
Ventilatory Threshold: An indirect measure of the lactate threshold that is based on non­
linear increases in metabolic gases. VT will be defined as the first sustained raise in YE/ 
VO2 without a rise in VE/VCO2 concurrent with the first rise in excess CO2 , and the first 
break above a slope o f 1.0 in the v-slope method.
Rate o f  Perceived Exertion (RPE): Subjective means for measuring an individual’s 
exertion level determined by the Borg scale from 6-20. A higher number indicates in 
increased perceived exertion.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter Two: Literature Review 
Heat and Metabolism by Sequence of Time
Brooks et al. ‘ studied the phosphorylative efficiency o f isolated rat muscle 
mitochondria in vitro by examining the ADP/O ratio over several varying temperatures. 
Between 25®C and 40°C they observed constant ADP/O ratios. However as muscle 
temperature increased above 40®C, the ADP/O ratio decreased linearly. These findings 
suggest that for a given VO2 the rate of ATP degradation was higher than ADP 
rephosphorylation.
In a study by Fink et al. subjects performed work in heat (41®C) and cold (9®C) 
to assess the effects of environmental stress on muscle metabolism during exercise. Each 
trial consisted of work at 70-85% of VO2 max for 3-bouts o f 15-minutes each with a 10- 
minute rest in between each bout. Findings showed that heart rate, rectal temperature, 
muscle glycogen utilization and blood lactate were all significantly higher in the heat. 
Subjects showed reduced muscle triglyceride depletion during exercise in the heat, yet 
serum triglycerides levels were slightly lower with exercise in the heat. Plasma free fatty 
acid levels were not different between the trials. In conclusion, Fink noted that blood and 
muscle lipids indicate a trend toward less lipid metabolism in the heat than in the cold.
An enhanced rate of glycolysis during the heat was reflected by a greater lactate 
production and glycogen utilization.
Young et al. studied the effects of heat acclimation on muscle metabolism during 
submaximal exercise Subjects were asked to cycle for 30-minutes at 70% maximal
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
VO2 in a cool (21°C) and hot (49"C) environment and again after acclimatization. RER 
and plasma lactate were significantly higher in the heat trials compared with the cold 
trials. Muscle glycogen utilization did not differ at any point between the heat and cold 
trials. Acclimation lowered aerobic metabolic rate and plasma lactate in both 
temperatures. Young concluded that the increased plasma lactate during heat is not 
resultant upon increased glycogen since no differences in muscle glycogen were found.
Using 11 dogs as subjects, Kozlowski et al. found that trunk cooling with ice 
packs improved total running performance. Cooling resulted in a reduced muscle 
glycogen depletion and blood lactate (p<0.05). Following the exercise to exhaustion, 
muscle ATP was higher (p<0.01), ADP content was lower (p<0.05) and AMP content 
was lower (p<0.01) in cooled dogs. Kozlowksi concluded that hyperthermia promoted 
lactate accumulation and more rapid glycogen depletion possibly accounting for local 
fatigue and decreased performance.
Febbraio et al. ® had subjects cycle for 40 minutes at 70% peak VO2 in ambient 
temperatures of 20"C and 40“C to examine the effects of heat on metabolism. RER, 
muscle glycogenolysis, lactate and heart rate were significantly higher in the heat 
(p<0.05). Rectal temperatures were higher and creatine phosphate stores were lower in 
the heat trial (p<0.05). There were no differences in post exercise ATP/ADP ratio or 
IMP concentrations possibly indicating that although ATP demand is increased in the 
heat, the demand is met by an increase in anaerobic glycolysis and creatine phosphate 
hydrolysis.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Febbraio et al. looked at the influence of elevated muscle temperature on 
metabolism during intense, dynamic exercise. Subjects underwent 2 trials consisting of a 
2-minute workload at 115% maximal VO2 , either without preheating (CT) or after having 
their thigh wrapped in a heating blanket for 60-minutes (HT). Core temperature was not 
affected by the heating but muscle temperature within the thigh was significantly 
different (p<0.01). Muscle glycogen and lactate concentrations were not different before 
exercise, but lactate concentrations were higher in HT and glycogen concentrations were 
lower in HT (p<0.05). During exercise ATP degradation was higher in HT than CT 
(p<0.05). Febbraio suggests that increased adenine nucleotide degradation will result in 
further allosteric activation o f enzymes such as glycogen phosphorylase, PFK, and LDH. 
He concludes that elevated nmscle temperature increases glycogenolysis, glycolysis, and 
high-energy phosphate degradation during exercise.
In a study done in 20“ C and 3“C ambient temperatures, Febbraio et al.  ̂ found 
that exercise in cool ambient temperature attenuated glycogen depletion. Heart rate, 
plasma catecholamines and rectal temperature were significantly higher (p<0.05) during 
the heat trial. Lactate and blood glucose levels were not significantly different.
However, muscle glycogen levels were significantly higher in the cool trial. Febbraio 
reasons that findings of a higher RER in the cool trial may be due to involuntary activity 
in muscles associated with shivering.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Using fit horses. Mills et al. showed that high temperature and humidity 
exacerbate oxidative stress during exercise. Horses performed prolonged variable- 
intensity and short-term high intensity exercises under 20"C, 40% relative humidity or 
30”C, 80% relative humidity. Horses were unable to complete the exercise protocol in 
the high heat trial. Correlations (r=0.85) were found between the final stages o f exercise 
in the hot/humid trial and lipid hyperoxides, indicating oxidative stress. Mills concluded 
that heat and humidity amplified the induced changes in biochemical parameters, which 
indicate oxidative stress.
Recently, Sial et al. looked at the effects of aging on substrate oxidation. At 
similar relative intensities, equivalent to 56% VO2 max in the elderly group, carbohydrate 
was 40% lower (p<0.001) and fat oxidation was 25-35% lower (p<0.05) in the elderly 
group. Sial concluded that the shift in substrate oxidation was caused by age-related 
changes in skeletal muscle respiratory capacity.
In a study conducted by Hargreaves et al. subjects were studied during 40- 
minutes of cycling at a workload equivalent to 65% VO2 max. Trials were randomly 
performed in ambient temperatures o f 20°C (CT) and 40®C (HT). Glucose rate of 
appearance and disappearance was measured using a primed infusion of a glucose 
isotope. Following 40-minutes of exercise, heart rate, rectal temperature, RER, and 
plasma lactate were all higher (p<0.05) in HT compared with exercise in CT. Plasma 
glucose levels were higher following exercise in HT (p<0.05) due to an increase in 
hepatic glucose production. Glucose rate of disappearance and metabolic clearance rate
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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was not different at any point. Hargreaves concluded that hyperglycemia observed 
during the heat was caused by in increase in liver glucose without any change in whole 
body glucose utilization.
Galloway et al.  ̂found that the effects of temperature on exercise capacity follow 
an inverted U relationship. During trials in temperatures o f 3.6“C, 10.5“C, 20.6®C and 
30.5®C, exercise time was the greatest during the 11”C trial. RER was the lowest and fat 
oxidation highest during the 1 l^C trial. In temperatures higher than 11®C, RER increased 
although carbohydrate oxidation rates were highest (p<0.05) during the 4®C trial. 
Galloway concluded that the optimal temperature for prolonged exercise from this study 
was 11"C.
Starkie et al, used water cuffs to examine the effects of temperature on 
metabolism during submaximal exercise. 40-minutes prior to exercise, each subject had 
one thigh warmed with 55"C water (HL) and the other thigh cooled with 0”C (CL) water 
via water-perfused cuffs and continued wearing them throughout the trial. Subjects 
performed at 70% VO2 peak for 20 minutes. Results from muscle biopsy showed that 
muscle glycogen levels were lower in the HL thigh (p<0,05). Muscle ATP 
concentrations were not different post exercise when comparing HL to CL. Starkie 
concluded that the increase in CHO utilization was a direct result of elevated muscle 
temperature and was not secondary to allosteric activity from enzymes mediated by a 
reduced ATP content.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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A study from Gonzalez-Alonso et al. ’ ̂  used dehydration-induced reductions in 
blood flow to examine substrate delivery and utilization. Subjects performed two 
separate trials at 61% VO2 max in 35°C heat. The first trial (DE) was done until 
voluntary exhaustion without any hydration and developing hyperthermia (39.7‘*C). The 
second trial (CON) was performed for the same length of time, except fluid ingestion was 
allowed and core temperatures only reached 38.2®C. Following 20-minutes o f exercise, 
leg blood flow was decreased in DE (p<0.05). DE resulted in a lower (p<0.05) FF A 
uptake, higher glycogen utilization and higher muscle lactate production. Plasma glucose 
and FFA levels were not different between trials. Gonzalez-Alonso concluded that 
hyperthermia was the main factor in fatigue in the heat.
In a review article, Febbraio states that  ̂ if exercise is submaximal in nature and a 
>.5"C increase in body temperature is observed, intramuscular carbohydrate utilization is 
being augmented. He also suggests that when the body is unable to dissipate heat, 
augmenting the exercise induced rise in core body temperature and perceived effort, a 
feed forward increase in epinephrine secretion results. This increase in epinephrine 
further augments glycogen utilization in contracting skeletal muscle. Increased muscle 
temperature may also impair muscle and metabolic function limiting oxidative 
phosphorylation in the heat.
In a review article regarding alterations in energy metabolism during heat stress, 
Febbraio  ̂sites findings by Fink et al.  ̂and Gonzalez-Alonso et al. that heat stress 
does not alter plasma free fatty acid, but reduces contracting free fatty acid uptake.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Febbraio suggests that free fatty acid release by adipocytes may be reduced during 
exercise in the heat.
Body Composition and Substrate Selection
To find the optimal intensity to oxidize fats, Looper et al. had subjects perform 
at 70, 85 and 100% ventilatory threshold (VT). Subjects were separated into two groups, 
those with low fat mass (10.5±2.3%) and recreational fitness levels (recfit-lowfat) and 
those with high fat mass (27.1±5%) and low fitness levels (lowfit-highfat). Fat oxidation 
was highest at 70% VT for the lowfit-highfat group and decreased with increased 
intensities. There were no significant differences between intensities for the recfit-lowfat 
group. Fat oxidation was not different between groups at 70% VT, but was significantly 
lower at 85% VT and 100% VT in the lowfit-highfat group. Looper concluded that with 
increased fitness and decreased fat mass, individuals are better able to maintain higher 
rates of fat oxidation over a range of moderate intensities.
Gender and Substrate Selection
Comparing gender and substrate utilization, Tamopolsky et al. found that 
women oxidized significantly more lipid and less protein and carbohydrate compared 
with the men during exercise at 75% VOz-peak. Also, after an attempt to increase muscle 
glycogen through 4 days of carbohydrate loading, women did not increase muscle 
glycogen stores whereas men did. Tamopolsky concluded that his data supports previous 
observations of greater lipid and lower carbohydrate and protein oxidation by women 
versus men during submaximal endurance exercise.
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Chapter Three: Methodology 
Setting
All exercise testing took place at The University of Montana, Human 
Performance Laboratory.
Subjects
Sixteen apparently healthy college aged men participated in the study. Subjects 
were divided into two groups based on their body composition. Men with >18% fat mass 
(n=8) were placed in the high fat group (group 1) and men with <10% fat mass (n=8) 
were placed in the low fat group (group 2). Prior to participation, each subject completed 
an IRB approved informed consent form.
Descriptive Data
Prior to testing, the following descriptive data was obtained: age, height (cm) and 
body weight (kg) using a calibrated digital scale model PS6600T (Belfour Inc., 
Cedarburg, WI). Residual lung volume was measured using the helium dilution method 
(Collins Modular Lung Analyzer, Greensboro, NC). Hydrostatic weight was measured 
with a digital underwater scale (Exertech, Dresbach, MN). Body density was calculated 
using an average o f three underwater weights within 100 grams of each other and 
corrected for residual volume. Body density was converted to percent fat using the Siri 
equation
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Exercise Testing
For the initial session subjects completed a graded exercise test on a Monark 
824E mechanically braked cycle ergometer (Varberg, Sweden) to determine ventilatory 
threshold (VT) and VO2 max. The graded exercise for VT consisted of 1-minute stages 
until exhaustion. The first stage was performed at approximately 70-watts and each 
subsequent stage consistes of a 15-watt increase. Cadence was maintained at 70 
revolutions per minute. Expired gas was collected and analyzed at 15-second intervals 
using a calibrated Parvo Medics metabolic cart (Parvomedics, Inc., Salt Lake City, UT). 
VT was determined using a combination of the V-slope method, the ventilatory 
equivalent method and the excess CO2 method
Trials
Each subject was asked to refrain from strenuous exercise, caffeine, alcohol, and 
tobacco for 24-hours prior to the trial. Subjects were asked to keep a 1-day food diary the 
day before the test and follow it for each subsequent trial. All trials were performed in 
the morning following a 10-hour fast. Subjects exercised at a work rate equivalent to 
90% of VT for 45-minutes on a cycle ergometer. Exercise chamber temperature was 
controlled at 28®C for both trials. Subjects received either cooling (WC, 22®C) from the 
AVAcore hand device or no cooling (NC) in a random repeated measure. Core body 
temperature was continuously recorded using an Omega data logger and Mon-a-therm 
(Mallinkrodt Medical, Inc.) rectal probe inserted at least 10 cm. Heart rate was recorded 
every 10-minutes using a chest strap heart rate monitor (Polar, Port Washington, NY). 
RPE was recorded every 10-minutes. Blood lactate samples were taken at minute 0, 15,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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25, 35 and 45. RER was recorded at minutes 5, 15, 25, 35 and 45. Whole body 
carbohydrate and fat oxidation were calculated from VO2 and VCO2 measures collected 
at minutes 5, 15, 25, 35 and 45 using the Frayn equation*. Following the completion of 
each trial, a passive recovery took place for 10-minutes.
Statistics
RER, HR, RPE, fat oxidation and CHO oxidation were examined using pre­
planned comparison between trials for each group individually during minutes 5, 15, 25, 
35, and 45. Pre-planned comparisons examined differences in RER, HR, RPE, fat 
oxidation and CHO oxidation at minute 5 vs. 25 and 5 vs. 45 within trials for both groups 
individually. Temperature was analyzed between groups with pre-planned comparisons 
between trials at minutes 0, 5, 15, 25, 35, 45, and 10-minutes post. Within each trial pre­
planned comparisons examined differences between minute 0 vs. 25, 0 vs. 45 and 45 vs. 
10-minute post for both groups individually. Blood lactate was examined using pre­
planned comparison between trials for each group individually during minutes 0, 15, 25, 
35, and 45. Pre-planned comparisons will examine differences in blood lactate at minute 
0 vs. 25 and 0 vs. 45 within trials for both groups individually. Significance level was set 
at p<0.05.
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Descriptive Data
Table 1. Group 1
Subject Age Ht.
inches
W t.
kg
% body fat Peak V 0 2  (L/min) VT (L/min) % V 0 2  at VT
9 24 71.5 90.2 18.1 3.15 2.0 0.63
10 25 69 94.6 20.6 3.60 2.2 0.61
11 30 70.5 95.0 22.7 4.43 2.8 0.63
12 30 68 88.2 18.1 3.51 2.2 0.61
13 36 72 104.7 26.4 4.13 2.8 0.69
14 37 73 110.3 27 3.87 2.4 0.62
15 19 72 84.35 18.2 2.98 2.7 0.57
16 23 71 144.8 38.7 3.49 1.9 0.56
Table 2. Group 2
Subject Age Ht.
Inches
Wt.
kg
% body fat Peak V 02 (L/min) VT (L/min) % V02 at VT
1 23 70.7 77.6 4.9 4.24 2.8 0.66
2 32 70.3 68.1 6.2 3.76 2.5 0.66
3 22 73.5 65.9 3.1 4.34 2.8 0.65
4 28 66.5 67.9 6.6 4.44 2.6 0.59
5 20 73 68.8 9.9 4.23 2.9 0.67
6 19 66 61.1 5.2 4.07 3.0 0.74
7 21 71 66.8 5.5 4.87 2.6 0.73
8 19 69 82.9 4.2 3.91 2.2 0.56
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CHO Utilization
For group 1, NC showed significantly greater CHO use at minutes 5 and 25. NC showed 
significant decreases in CHO utilization between minutes 5 and 25, and between minutes 
5 and 45. All other pre-planned comparisons were not significantly different.
For group 2, CHO utilization during NC was significantly greater at minutes 5, 15, and 
45 compared with WC. During NC, CHO utilization dropped significantly between 
minutes 5 and 25, and between minutes 5 and 45. All other pre-planned comparisons 
were not significantly different.
Fat Utilization
For group 1, WC resulted in significantly greater fat utilization at minutes 5 and 25. 
During both NC and WC, fat utilization increased significantly between minutes 5 and 
25, and between minutes 5 and 45 for group 2. All other pre-planned comparisons were 
not significantly different.
For group 2, fat utilization was significantly greater during WC at minutes 5, 15, 25, and 
45. During both NC and WC, fat utilization increased significantly between minutes 5 
and 25, and between minutes 5 and 45 for group 1. All other pre-planned comparisons 
were not significantly different.
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RER
For group 1, NC resulted in significantly higher RER values at minutes 5 and 25. Both 
NC and WC resulted in significant decreases in RER between minutes 5 and 25, and 5 
and 45. All other pre-planned comparisons were not significantly different.
For group 2, RER was significantly higher at minutes 5, 15,25, and 45 during NC. Both 
NC and WC resulted in significant decreases in RER between minutes 5 and 25, and 5 
and 45. All other pre-planned comparisons were not significantly different.
Heart Rate
For group 1, HR was significantly lower at minute 5 during WC. For both NC and WC, 
HR increased between minutes 5 and 25, and between minutes 5 and 45. All other pre­
planned comparisons were not significantly different.
For group 2, there were no significant differences between trials at any point. For both 
NC and WC, HR increased between minutes 5 and 25, and between minutes 5 and 45.
All other pre-planned comparisons were not significantly different.
RPE
For group 1, RPE was significantly lower during WC at minutes 25 and 45 compared 
with NC. For both NC and WC, RPE increased between minutes 5 and 25, and between 
minutes 5 and 45. All other pre-planned comparisons were not significantly different.
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For group 2, there were no significant differences between trials at any point. For both 
NC and WC, RPE increased between minutes 5 and 25, and between minutes 5 and 45. 
All other pre-planned comparisons were not significantly different.
Temperature
For group 1, there were no significant differences between NC and WC at any point.
Both NC and WC resulted in increased rectal temperature between minutes 0 and 25, 
minutes 0 and 45, and decreased rectal temperature between minutes 45 and 10-minute 
post. All other pre-planned comparisons were not significantly different.
For group 2, there were no significant differences between NC and WC at any point.
Both NC and WC resulted in increased rectal temperature between minutes 0 and 25, and 
0 and 45. There was no significant difference between minutes 45 and 10-minute post for 
the NC trial. All other pre-planned comparisons were not significantly different.
Lactate
For group 1, there was a significant difference between NC and WC at minute 45. WC 
resulted in significant differences between minutes 5 and 25, but non-significant 
differences between minutes 5 and 45. NC resulted in significant differences between 
minutes 5 and 25, and between minutes 5 and 45.
For group 2, there were no significant differences between trials. Both WC and NC 
resulted in significant differences between minutes 5 and 25, and minutes 5 and 45.
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Appendix I Attachments
H UM AN PERFORM ANCE LABO RATO RY  
D ept o f Health and Human Perform ance 
UNIVERSITY O F M ONTANA  
M issoula, M ontana
SUBJECT INFORM ATION AND CO NSENT FORM
ID  # _________Today’s Date:_______/_____ / ______ Participant
(Print Name) M onth Day Year
EFFECTS OF PERIPHERAL COOLING ON MUSCLE FUEL UTILIZATION
DURING M ODERATE EXERCISE
STUDY D IR E C T O R : B rent Ruby, Ph.D. (406)243-2117 University o f  M ontana
STUDY SPO N SO R : AVA core Technologies (650) 321 -0824
This consent form may contain words that are new to you. I f  you read any words that are not 
clear to you, please ask the person who gave you this form to explain them to you,__________
PURPOSE O F THE RESEARCH
• You are being asked to take part in a research stutfy to examine the effects o f  hand/arm 
cooling on measurem ents o f  body temperature and m etabolism  during tw o sessions o f  
m oderate intensity exercise.
■ You have been chosen because you are 18-50 years o f  age, healthy, and a body fat 
<10% o r  with a  body fat >18%.
• During this study you wUl be performing two 45-minute exercise sessions o f  a 
submaximal, moderate intensity in a  controlled environm ent o f  75“ F.
PROCEDURES
On your first visit to  the lab we will measure your height and weight and body fat.
Body fat will be determined by using hydrostatic weighing. Body density will be calculated 
using an average o f  3 underwater weights within 100 grams o f  each other. Body fat will be 
determined fi-om the average body density. Residual lung volume wUJ be determined using the 
helium dilution method.
I f  your percent body fet values are less than 10% or greater that 18%, you are eligible for 
participation in the study.
On your second visit, you will be asked to perform the following exercise test;
A maximal treadmill test (cycling) to determine your level o f  aerobic fimess. The performance o f 
a maximal test allows the tester to determine the participant’s m aximal volume o f  oxygen 
breathed in, which is a  m easure o f  fitness. This test will also allow us to determine your 
ventilatory threshold, which will allow us to  compute the speed and grade for your two heated 
exercise sessions. This testing will take approximately 1 hour.
R e v is e d  Q/7A/07.
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2. You will receive information concerning your maximal aerobic capacity and ventilatory 
threshold, which you may compare with norms for your age, sex  and sport. There are no 
other direct benefits to the participants in the study.
CONFIDENTIALITY
1. Your records w ill be kept private and w ill not be released without your consent except as 
required by law.
2. Only the researcher and his research assistants w ill have access to the files.
3. Your identity w ill be kept confidential.
4. I f  the results o f  this stu(fy are written in a scientific journal or presented at a scientific 
meeting, your name will not be used.
5. A ll data, identified only by an anonymous ID #, w ill be stored in our laboratory.
6. Your signed consent form and information sheet w ill be stored in a locked office separate 
from the data
COMPENSATION FOR INJURY
Although w e believe that the risk o f  taking part in this study is minimal, the following liability 
statement is required in all University o f  Montana consent forms.
" /«  the event that you are injured as a result o f  this research you should individually seek 
appropriate medical treatment. I f  the injury is caused by negligence o f  the University or any o f  
its employees, you may be entitled to reimbursement pursuant to the Comprehensive State 
Insurance Plan established by the Department o f  Administration under the authority ofM.C.A., 
Title 2, Chapter 9. In the event o f  a claim fo r  such injury, further information may be obtained 
p o m  the University's Claim representative or University Legal Counsel, ”
VOLUNTARY PARTICIPATION/WITHDRAWAL
1. You have the right to request that a test be stopped at any time.
2. Your decision to take part in this research study is entirely voluntary.
3. You m ay refuse to take part in or you may withdraw firom the study at any time without 
penalty or loss o f  benefits to which you are normally entitled.
4. You may leave the study for any reason.
You may be asked to leave the study for any o f  the following reasons:
1. Failure to follow the study investigator’s instmctions.
2. A serious adverse reaction, which may require evaluation.
3. The study director/investigator thinks it is in the best interest o f  your health and welfere.
4. The study is terminated.
QUESTIONS
• You m ay wish to discuss this with others before you agree to take part in this study.
• I f  you have any questions about the research now or during the study contact: Brent Ruby (406) 
243-2117.
• If you have any questions regarding your rights as a research subject, you may contact the 
Chairman, J.A. Rudbach, o f  the IRB through the Research Office at the University o f  Montana at 
243-6670.
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On youi- third and fourth visit we will measure your responses during a 45 minute exercise ttial in 
a climate controlled room (approximately 75°F). This trial will proceed on a morning after a 12 
hour fast. Before die exercise trial, you will place a flexible rectal thermometer so that your core 
body temperature can be monitored throughout each trial. During the exercise, one ann/hand will 
be kept cool using a cooling device that creates a low-pressure environment to draw blood into 
the band and cools that blood by absorbing heat from the overlying skin. We will also ask you to 
rate your level o f  fatigue during the exercise using a 6-20 number scale. Your heart rate will be 
measured during the exercise using a chest strap heait rate monitor. During the exercise, a small 
blood sample will be periodically obtained from your finger tip (every 10-minutes) to allow us to 
measure blood lactate. During the exercise trials, you will not be provided with any water until 
die exercise period ends as it enhances body cooling. As a result, it is anticipated that you will 
get thirsty during your participation. Periodically, you will wear a mouthpiece and nose clip so 
that samples o f  your exhaled air can be collected and analyzed to determine the amount o f  oxygen 
your botfy is consuming during exercise. You will be asked to repeat the same exercise but 
without the cooling device. All other measurements listed above will be collected during both o f  
the 45-minute trials. It is expected ftiat these two visits to our lab will take ^proximately 1 to 1 
1/2 hours o f  your time..
LOCATION AND LENGTH OF TIME REQUIRED
The study will take place at the in the Human Performance Laboratory in McGill Hall (First Floor 
-  enter main doors, go straight through lobby, then enter lab via first door to the right.)
PAYMENT
There is no payment for participation.
RISK/DISCOMFORTS
1. Mild discomfort may result during and after die exercise. These discomforts include 
shortness o f  breath, tired or sore legs, nausea and possibility o f  vomiting.
2. Muscle soreness after the tests may occur as a result o f  the exercise, but should not persist.
3. Certain changes in body function take place when any person exercises. Some o f  these 
changes are normal and others are abnormal. Abnormal changes may occur in blood 
pressures, heart rate, heart rhythm or extreme shortness o f  breath. Vary rare instances o f  
heart attack have occurred, as with other moderately strenuous exercise activities. Every 
effort will be made to minimize possible problems by the preliminary evaluation and constant 
surveillance during testing. Equipment and trained personnel are available to deal with 
unusual situations should they arise. A  trained CPR technician will be on hand at all times 
and the laboratory has standard emergency procedures should any potential need arise,
4. Mild symptoms o f  dehydration such as headache and general fatigue may result during and 
after the exercise. To minimize the risk o f  excessive dehydration, your body temperature will 
be monitored continuously during exercise. Immediately after the exercise sessions, sports 
drinks or juices (electrolytes) along with walei' will be provided to you.
5. You will be informed o f  any new findings that may affect your decision to remain in the 
study.
6. During any o f  the exercise tests should symptoms, such as chest discomfort, unusual 
shortness o f  breath or other abnormal findings develop, the exercise physiologist conducting 
the research will terminate the test. Guidelines by the American College o f  Sports Medicine 
will be followed to determine when a test should be stopped.
BENEFITS OF PARTICIPATING IN THIS STUDY
1. Tliere is no promise that you will receive any benefit from taking part in tliis study.
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SUBJECT’S STATEMENT OF CONSENT
I have read the above description o f  this research study. I have been informed o f  the risks and 
benefits involved, and all my questions have been answered to my satisfaction. Furthermore, I 
have been assured that a member o f  the research team will also answer any future questions I may 
have. I voluntarily agree to take part. I understand I will receive a copy o f  this consent form.
Printed (Typed) Name o f  Subject
Subject’s Signature Date
SUBJECT’S STATEMENT OF CONSENT TO BE PHOTOGRAPHED DURING DATA 
COLLECTION
I provide my consent to be photographed during periods o f  the data collection. I realize 
that these digital images may be used during presentation o f  the data at regional and national 
meetings.
Subject’s Signature Date
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P h y s i c a l  A c tn n iy  _
PAR - Q  & YOU
{A Q u e s t i o n n a i r e  f o r  P e o p l e  A g e d  1 5  to  6 9 )
R egu lar physical activity is lun and  healthy , and  increasing ly  m ore  peop le  a re  starting to b eco m e m ore active every  day Being m ore 
active Is very s a le  lor most peop le . However, som e peop le  should check with their doc to r be lo re  they start becom ing much more 
physically active.
If you are planning to becom e m uch m ore physically active than  you a re  now. s la r t by answ ering  the sev en  questions in the box below. II 
you are  betw een the a g es  of 15 and  69, the  PAR-Q will tell you W you should check with your doctor before you start. II you are over 69 years 
ol ag e , and y ou  are  not used  to being very active, check  with your doctor.
Common s e n s e  is your best guide w hen  you an sw er th e se  questions. P le a se  read  Ihe q uestions  carefully an d  answ er each  one honestly: 
c h e c k  YES o r  NO.
Has your doctor ever said  that you have a  heart condition an d  that you should  only do  physical activity 
recom m ended by a  doctor?
Do you feel pain in your ch est w hen you do physical activity?
In the p ast m onth, h ave  you had  ch est pain w hen  you w are not doing physical activity?
Do you lose your ba lance  b ecau se  of d izziness or do you e v er lose consc io u sn ess?
Do you have  a  h one  or joint problem that could tœ  m ade w orse  by a  c hange  in your physical activity?
Is your doctor currenBy prescribing drugs [for exam ple, w ater pills) for your blood p re ssu re  or heart condition? 
Do you know of any  other reason  why you should not do  physical activity?
YES NO
□ □ 1.
□ □ 2.
□ □ 3.
□ □ 4.
□ □ 5.
□ □ 6.
o □ 7.
If
you
answered
YES to one or more questions
TaJk with your doctor by phone or in person BEFORE you start becoming much more physicaiiy achve or BEFORE you have a 
fitness appralsaf. Tell your doctor about the PAR-0 and which questions you answered YES.
• You may be able to do any activity you want—as  tong as you start slowly and build up gradually. Or. you may need to restrict 
your activities to tiiose which safe for you. Talk with your doctor about the kinds of activities you wish to participate in 
and loHow his/her advice
• Find out which community programs are safe and helpful for you.
NO to all questions
If you answered NO honestly to ^  PAR-Q questions, you can be 
reasonably sure that -^ u  can:
• start becoming much more physically active—begin slowly and build 
up gradually. This is the safest and e a s ie r  way to go.
- lake pari in a fitness aopraisst—this is an excellent way to determine 
your basic fitness so thal you can plan the best way (or you to live 
acHvely.______________________________________________________
DELAY BECOMING MUCH MORE ACTIVE;
* if you are not feeling well because of a  temporary illness such 
a s  a  (xXd or a  fever—wait until you (eel better: or 
> if you are or may be pregnant—tadk to your doctor before you 
start becoming more active.
7 0 (3 =
t^q i;rr .w s U s e  o f  m *  P A fl-Q : T h e  C a n a d ia n  S o o e ty  for E x e rc is e  P h y s io lo g y . H e a lth  C a n a d a ,  a n d  th e ir  a g e n t s  a s s u m e  n o  (iability lo r  p e r s o n s  w h o  u n d e r ta k e  p h y s ic a l  a c tiv ity , a n d  
#1 m  d o u o t a lte r  c o m p le t in g  tm s  q u e s t io n n a ir e ,  c o n s u l t  y o u r  d o c to r  p n o r  to  p h y s ic a l activ ity .
You are encouraged to copy the PAR-Q but only if you u se  the entire form
I have read, understood and completed this questionnaire. Any questions I had were answered to my full satisfaction.
SIG N A T U R E  O F  P A R E N T  . ____________________
o r  GUAROIAN (lor p a r t i c i p a n t  u r u o r  th a  a g e  o l m atonfy}
© Canadian Socipfy far £jee/&se Physiofogy 
Scciéie canadienne de physioiogie cfe rexerctce
Supported by:
a Health SamA C a n a d a  C a n a d a
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Appendix II; Statistics
Group 1 RER
Type III Sum s of Squares
Source df Sum of Squares Mean Square
Dependent: RER
F-Va(ue P-Value G-G H-F
Subject 7 .031 .004
Trial 1 .003 .003 3283 .1129 .1129 .1129
Trial * Subject 7 .007 .001
time 4 .015 .004 15,590 .0001 .0002 .0001
time * Subject 28 .007 2.369E-4
Trial "tim e 4 .003 .001 6.469 .0008 .0041 .0008
Triai * time * S ... 28 .003 1.052E-4
Means Table 
Effect: Trial 
Dependent: RER
C o u n t M ean S td . D ev. S td . E rro r
with 4 0 .9 0 3 .030 .0 0 5
w ithout 4 0 .9 1 5 .027 .0 0 4
Means Table 
Effect: time 
Dependent: RER
C o u n t M ean S td . D ev. S td . E rro r
5  m in 16 .9 3 3 .034 .0 0 8
15 m in 16 .912 .026 .006
2 5  m in 16 .9 0 8 .023 .0 0 6
3 5  m in 16 .8 9 8 .0 2 3 .0 0 6
4 5  m in 16 .8 9 4 .0 2 6 .006
Means Table 
Effect: Trial * time 
Dependent: RER
with, 5 min 
with, 15 min 
with, 25 min 
with, 35 min 
with. 45 min 
without, 5 min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 .916 .036 .013
8 .911 .031 .011
a .899 .025 .009
8 .897 .027 .010
8 .890 .031 .011
8 .949 .023 .008
8 .914 .022 .008
8 .917 .019 .007
8 .898 .019 .007
8 .899 .021 .008
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Interaction Plot 
Effect; Trial *time 
Dependent: RER
With Standard Deviation error bars.
.98
.96
.94 -
i  ■
% .92 -
I
a
.88
.86
.84
5 min 15 min 25 min 
time
35 min 45 min
O
■
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares .004
Mean square .004
F-Value 41.233
P-Value .0001
G-G .0001
H-F .0001
With min 15 vs. Without min 15
df 1
Sum o f  squares 3.655E-5
Mean square 3.655E-5
F-Value .348
P-Value .5602
G-G .4793
H-F .5602
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f squares .001
Mean square .001
F-Value 11.160
P-Value .0024
G-G .0071
H-F .0024
With min 35 vs. Without min 35
df 1
Sum o f  squares 1.896E-6
Mean square 1.896E-6
F-Value .018
P-Value .8941
G-G .8032
H-F .8941
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares 3.228E-4
Mean square 3.228E-4
F-Value 3.070
P-Value .0907
G-G .1044
H-F .0907
With min 5 vs. With min 25
df 1
Sum o f  squares .001
Mean square .001
F-Value 10.816
P-Value .0027
G-G .0078
H-F .0027
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f squares .003
Mean square .003
F-Value 27.083
P-Value .0001
G-G .0002
H-F .0001
Without min 5 vs. Without min 25
df 1
Sum o f squares .004
Mean square .004
F-Value 40.570
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares .010
Mean square .010
F-Value 97.481
P-Value .0001
G-G .0001
H-F .0001
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Group 1 HR
Type III Sum s o f Squares
Source df Sum of Squares
Dependent: HR
Mean Square F-Value P-Value G-G H-F
Subject 7 12279.934 1754.276
Trial 1 20.211 20.211 .335 .5810 .5810 .5810
Trial * Subject 7 422.714 60.388
time 4 4327.352 1081.836 39.892 .0001 .0001 .0001
time * Subject 28 759.332 27.119
Trial * time 4 41.309 10.327 1.129 .3631 .3518 .3596
Trial * time * S ... 28 256.183 9.149
Means Table 
Effect: Trial 
Dependent; HR
C o u n t M ean S td . D ev. S td . E rro r
w ith 4 0 1 3 3 .5 0 8 1 5 .2 0 2 2 .4 0 4
w ithou t 4 0 1 3 4 .5 1 4 1 5 .2 5 4 2 .4 1 2
Means Table 
Effect: time 
Dependent: HR
C o u n t M ean S td . D ev. S td . E rro r
5  m in 16 1 2 2 .5 7 2 1 2 .4 1 5 3 .1 0 4
15 m in 16 1 2 9 .6 1 8 1 3 .8 2 9 3 .4 5 7
2 5  m in 16 1 3 4 .5 6 4 1 2 .8 4 8 3 .2 1 2
3 5  m in 16 1 4 0 .3 6 8 1 4 .6 5 7 3 .6 6 4
4 5  m in 16 1 4 2 .9 3 3 1 3 .9 0 5 3 .4 7 6
M eans Table 
Effect: Trial * time 
Dependent: HR
with, 5 min 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 5 min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 120,681 12,265 4.336
8 129.196 12,984 4.591
8 134,304 13.424 4,746
8 140,296 15.308 5,412
8 143,065 13,671 4.834
8 124.464 13.102 4.632
8 130.040 15,518 5,487
8 134.824 13,168 4,656
8 140.440 15,032 5,315
8 142.801 15,080 5.331
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Interaction Plot 
Effect: Trial * time 
Dependent: HR
With Standard Deviation error bars.
X
"S
I
Ô
160
150
140
130
120
110
100
5 min 15 m in 25 min 35 min 45 min
time
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares 57.229
Mean square 27.229
F-Value 6.255
P-Value .0185
G-G .0410
H-F .0292
With min 15 vs. Without min 15
df 1
Sum o f  squares 2.848
Mean square 2.848
F-Value .311
P-Value .58314
G-G .4387
H-F .5113
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares 1.082
Mean square 1.082
F-Value .118
P-Value .7335
G-G .5573
H-F .6494
With min 35 vs. Without min 35
df 1
Sum o f  squares .083
Mean square .083
F-Value .009
P-Value .9250
G-G .7693
H-F .8604
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares .278
Mean square .278
F-Value .030
P-Value .8628
G-G .6857
H-F .7838
With min 5 vs. With min 25
df 1
Sum o f squares 742.290
Mean square 742.290
F-Value 81.130
P-Value .0001
G-G .0001
H-F .0001
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 2004.129
Mean square 2004.129
F-Value 219.045
P-Value .0001
G-G .0001
H-F .0001
Without min 5 vs. Without min 25
df 1
Sum o f  squares 429.318
Mean square 429.318
F-Value 46.923
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares 1345.056
Mean square 1345.056
F-Value 147.010
P-Value .0001
G-G .0001
H-F .0001
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Group 1 Fat utilization
Type III Sum s of Squares
Source df Sum of Squares Mean Square F'Value P-Value G-G H-F
Subject 7 82.936 11.848
Trial 1 4.023 40 2 3 4.857 .0634 .0634 .0634
Trial * Subject 7 5.798 .828
time 4 33.785 8.446 20.597 .0001 .0001 .0001
time * Subject 28 11.482 .410
Trial * time 4 4.265 1.066 4,562 .0058 .0402 .0277
Trial * time * S ... 28 6.545 .234
Dependent: Fat oxidation (pmol/kg/min)
Means Table 
Effect: Trial
Dependent; Fat oxidation (pmol^g/min)
C o u n t M ean S td . D ev. S td . E rro r
with 4 0 4 .0 5 8 1 .3 4 7 .2 1 3
w ithou t 4 0 3 .6 0 9 1 .3 7 8 .218
Means T able 
Effect; time
Dependent; Fat oxidation (pmol/kg/min)
C o u n t M ean S td . D ev. S td . E rro r
5  m in 16 2 .7 2 4 1 .3 3 0 .333
15  m in 16 3.581 1 .1 5 6 .2 8 9
2 5  m in 16 3 .9 3 9 1 .2 8 8 .3 2 2
3 5  min 16 4 .3 7 6 1 .0 7 0 .267
4 5  min 16 4 .5 4 9 1 .3 2 7 .3 3 2
Means Table 
Effect: Trial * time
Dependent: Fat oxidation (pmolfkg/min)
with, 5 min 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without. 5  min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 3,329 1.335 .472
8 3.680 1.412 .499
8 4.303 1.362 .482
8 4.335 1.098 .388
8 4.644 1.397 .494
8 2.120 1.084 .383
8 3.481 .921 .326
6 3.575 1.181 .418
8 4.416 1.115 .394
8 4.455 1.342 .474
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Interaction Plot 
Effect: Trial 'tim e
Dependent: Fat oxidation (pmol/kg/min) 
With Standard Deviation error bars.
o
5 -
1 -
 1--
6 min
 1---
15 min
 1---
25 min
time
 1---
35 min 45 min
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares 5.844
Mean square 5.844
F-Value 25.004
P-Value .0001
G-G .0023
H-F .0010
With min 15 vs. Without min 15
df 1
Sum o f  squares .158
Mean square .158
F-Value .676
P-Value .4179
G-G .3003
H-F .3309
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares 2.117
Mean square 2.117
F-Value 9.057
P-Value .0055
G-G .0260
H-F .0195
With min 35 vs. Without min 35
df 1
Sum o f squares .026
Mean square .026
F-Value .113
P-Value .4179
G-G .3003
H-F .3309
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Comparison 5
Effect; Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f squares .143
Mean square .143
F*Value .610
P-Value .4415
G-G .3135
H-F .3464
With min 5 vs. With min 25
df 1
Sum o f  squares 3.793
Mean square 3.793
F-Value 16.227
P-Value .0004
G-G .0075
H-F .0043
Comparison 7 
Effect; Trial * Time
Comparison 8 
Effect; Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 6.917
Mean square 6.917
F-Value 25.593
P-Value .0001
G-G .0013
H-F .0005
Without min 5 vs. Without min 25
df 1
Sum o f  squares 8.468
Mean square 8.468
F-Value 36.230
P-Value .0001
G-G .0007
H-F .0002
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f squares 21.809
Mean square 21.809
F-Value 93.306
P-Value .0001
G-G .0001
H-F .0001
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Group 1 CHO
Type III Sum s o f Squares
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 71120.364 10160.052
Trial 1 675.064 675.064 3.835 .0910 .0910 .0910
Trial * Subject 7 1232.048 176.007
time 4 2344.810 586.203 6.290 .0010 .0150 .0075
time * Subject 28 2609.508 93.197
Triai * time 4 1168.766 292.192 4.898 .0040 .0197 .0073
Triai * time * S ... 28 1670.232 59.651
Dependent: CHO oxidation (pmol/kg/mln)
Means Table 
Effect: Trial
Dependent: CHO oxidation (pmol/kg/min)
C o u n t M ean S td . D ev. S td . E rro r
with 4 0 1 0 9 .4 6 9 3 2 .1 6 7 5 .0 8 6
w ithout 4 0 1 1 5 .2 7 9 3 1 .9 4 3 5 .051
Means Table 
Effect: time
Dependent: CHO oxidation (pmol/kg/min)
C o u n t M ean S td . D ev. S td . E rror
5  m in 16 1 2 2 .2 2 6 3 6 .5 2 4 9 .131
1 5  m in 16 1 1 2 .3 1 7 3 2 .791 8 .1 9 8
2 5  m in 16 1 1 2 .4 0 9 2 8 .8 5 5 7 .2 1 4
3 5  m in 16 1 0 8 .2 2 4 3 2 .5 7 5 8 .1 4 4
4 5  m in 16 1 0 6 .6 9 3 3 0 .4 7 5 7 .6 1 9
Means Table 
Effect: Trial * time
Dependent: CHO oxidation (pmol/kg/min)
with, 5 min 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 5 min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 112.734 36.565 12.928
8 110.625 32.484 11.485
8 108.352 30.029 10.617
8 110.251 36.643 12.955
8 105.382 33.063 11.689
8 131.717 36.271 12.824
8 114.010 35.247 12.462
8 116.465 29.065 10.276
8 106.197 30.361 10.734
8 108.004 29.885 10.566
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Interaction Plot 
Effect: Trial* time
Dependent: CHO oxidation (pmoi/kg/min) 
Witli Standard Deviation error bars.
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Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares 1
Mean square 1441.531
F-Value 24.166
P-Value .0001
G-G .0009
H-F .0001
With min 15 vs. Without min 15
df 1
Sum o f squares 45.833
Mean square 45.833
F-Value .768
P-Value .3882
G-G .3194
H-F .3666
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares 263.251
Mean square 263.251
F-Value 4.413
P-Value .0448
G-G .0676
H-F .0527
With min 35 vs. Without min 35
df 1
Sum o f squares 65.732
Mean square 65.732
F-Value 1.102
P-Value .3028
G-G .2614
H-F .2907
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f squares 27.484
Mean square 27.484
F-Value .461
P-Value .5028
G-G .3992
H-F .4695
With min 5 vs. With min 25
df 1
Sum o f  squares 76.781
Mean square 76.781
F-Value 1.287
P-Value .2662
G-G .2364
H-F .2581
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 216.164
Mean square 216.164
F-Value .3624
P-Value .0673
G-G .0887
H-F .0753
Without min 5 vs. Without min 25
df 1
Sum o f  squares 930.555
Mean square 930.555
F-Value 15.600
P-Value .0005
G-G .0040
H-F .0011
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f squares 2249.368
Mean square 2249.368
F-Value 37.709
P-Value .0001
G-G .0001
H-F .0001
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Group 1 RPE
Type III Sum s o f Squares
S ource F-Value P-Value G-G H-F
Subject 7 108.972 15.567
Trial 1 4.753 4.753 2.838 .1359 .1359 .1359
Trial * Subject 7 11.722 1.675
time 4 97.831 24.458 11.574 .0001 .0083 .0071
time * Subject 28 59,169 2.113
Trial * time 4 ,981 .245 .867 .4956 .4415 .4682
Trial * time * S ... 28 7.919 .283
Dependent; RPE
Means Table 
Effect: Trial 
Dependent: RPE
C o u n t M ean S td . D ev. S td . E rror
with 4 0 1 2 .9 6 2 1 .7 6 6 .2 7 9
w ithout 4 0 1 3 .4 5 0 2 .0 5 6 .3 2 5
Means Table 
Effect: time 
Dependent: RPE
C o u n t M ean S td . D ev. S td . E rro r
5  m in 16 1 1 .3 4 4 1 .2 0 7 .3 0 2
15  m in 16 1 2 .7 5 0 1 .3 4 2 .3 3 5
2 5  m in 16 1 3 .3 4 4 1 .5 4 6 .3 8 7
3 5  m in 16 1 4 .1 5 6 1 .7 6 7 .4 4 2
4 5  m in 16 1 4 .4 3 8 2 .0 3 2 .5 0 8
Means Table 
Effect; Trial * time 
Dependent: RPE
with, 5 min 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 5 min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 11.250 1.309 .463
8 12.500 1,195 .423
8 12.938 1.208 .427
8 14.000 1.690 .598
8 14.125 1.885 .666
8 11.438 1.178 .417
8 13.000 1.512 .535
8 13.750 1.813 .641
8 14.312 1.945 .688
8 14.750 2.252 .796
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Interaction Plot 
Effect: Trial * time 
Dependent: RPE
Witt) Standard Deviation error bars.
17 -
16 -
14 -0
1 13 -
Ô  12 -
10  -
25 min5 min 15 min 35 min 45 min
time
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares .141
Mean square .141
F-Value .497
P-Value .4865
G-G .3698
H-F .4253
With min 15 vs. Without min 15
df 1
Sum o f squares 1.000
Mean square 1.000
F-Value 3.536
P-Value .0805
G-G .0940
H-F .0848
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares 2.641
Mean square 2.641
F-Value 9.337
P-Value .0049
G-G .0194
H-F .0112
With min 35 vs. Without min 35
df 1
Sum o f  squares .391
Mean square .391
F-Value 1.381
P-Value .2498
G-G .2193
H-F .2362
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares 1.562
Mean square 1.562
F-Value 5.525
P-Value .0260
G-G .0511
H-F .0393
With min 5 vs. With min 25
df 1
Sum o f squares 11.391
Mean square 11.391
F-Value 40.276
P-Value .0001
G-G .0002
H-F .0001
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 33.063
Mean square 33.063
F-Value 116.906
P-Value .0001
G-G .0001
H-F .0001
Without min 5 vs. Without min 25
df 1
Sum o f  squares 21.391
Mean square 21.391
F-Value 75.635
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect; Trial * Time
Without min 5 vs. Without min 45
d f 1
Sum o f  squares 43.891
Mean square 43.891
F-Value 155.193
P-Value .0001
G-G .0001
H-F .0001
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Group 1 Lactate
Type III Sum s of Squares
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 123.741 17.677
Trial 1 5.980 5.980 1.974 .2029 .2029 .2029
Trial * Subject 7 21.209 3 030
time 4 32.022 8.005 6.590 .0007 .0180 .0113
time * Subject 28 34.015 1.215
Trial * time 4 4.283 1.071 1.594 .2034 .2399 .2292
Trial 'tim e  * S ... 28 18.804 .672
Dependent; lactate (mM)
Means Table 
Effect: Trial
Dependent: lactate (mM)
C o u n t M ean S td . D ev. S td . E rro r
with 4 0 3 .4 0 7 1 .2 8 7 .204
w ithou t 4 0 3 .9 5 4 2 .0 8 4 .330
Means Table 
Effect: time
Dependent: lactate (mM)
C o u n t M ean S td . D ev. S td . E rro r
0  m in 16 2 .4 9 3 1 .0 2 3 .256
15 m in 16 3 .8 5 2 1 .3 8 0 .3 4 5
2 5  mln 16 3 .7 4 4 1 .3 1 0 .3 2 7
3 5  m in 16 4 .3 8 5 1 .9 4 8 .4 8 7
4 5  m in 16 3 .9 2 9 2 .3 2 5 .581
M eans Table 
Effect: Trial * time 
Dependent: lactate (mM)
with. 0 mln 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 0 min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 2.420 .887 .313
8 3.650 1.145 .405
8 3.697 1.186 .419
8 4.015 1.663 .588
8 3.253 1.111 .393
8 2.565 1.202 .425
8 4.054 1.636 .578
8 3.791 1.505 .532
8 4.754 2.249 .795
8 4.605 3.050 1.078
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Interaction Plot 
Effect: Trial * time 
Dependent: lactate (mM)
With Standard Deviation error bars.
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Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares .084
Mean square .084
F-Value .125
P-Value .7259
G-G .5268
H-F .6044
With min 15 vs. Without min 15
df 1
Sum o f  squares .655
Mean square .655
F-Value .975
P-Value .3319
G-G .2645
H-F .2917
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f squares .035
Mean square .035
F-Value .053
P-Value .8200
G-G .6120
H-F .6969
With min 35 vs. Without min 35
df 1
Sum o f  squares 2.183
Mean square 2.183
F-Value 3.251
P-Value .0822
G-G .1046
H-F .0988
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Comparison 5
Effect; Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares 7.305
Mean square 7.305
F-Value 10.877
P-Value .0027
G-G .0154
H-F .0090
With min 5 vs. With min 25
df 1
Sum o f  squares 6.520
Mean square 6.520
F-Value 9.709
P-Value .0042
G-G .0196
H-F .0123
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 2.775
Mean square 2.775
F-Value 4.132
P-Value .0517
G-G .0792
H-F .0705
Without min 5 vs. Without min 25
df 1
Sum o f  squares 6.040
Mean square 6.010
F-Value 8.949
P-Value .0057
G-G .0232
H-F .0152
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares 16.632
Mean square 16.632
F-Value 24.766
P-Value .0001
G-G .0016
H-F .0005
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Type III Sum s o f Squares
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 21,218 3 031
trial 1 .047 .047 .129 .7299 .7299 .7299
trial * Subject 7 2.529 .361
time 6 11.902 1.984 8.890 ,0001 .0108 .0074
time * Subject 42 9.372 .223
trial * time 6 .093 .015 1.254 .2990 .3152 .3162
trial * time * 8 ... 42 .517 .012
Dependent: rectal temp
Means Table 
Effect: trial
Dependent: rectal temp
C o u n t M ean S td , D ev, S td . E rro r
w ith 56 3 7 ,5 4 9 .634 .0 8 5
w ithout 56 3 7 .5 8 9 .654 .087
Means Table 
Effect: time
Dependent: rectal temp
0
5
15
25
35
45
10 min post
Count Mean Std. Dev. Std. Error
16 37.065 .564 .141
16 37 163 .496 .124
16 37.479 .425 .106
16 37.703 .437 .109
16 37.878 .434 .109
16 38.001 .457 .114
16 37.694 .958 .240
Means Tabla 
Effect: Mai * time 
Dependent: rectal temp
w lh ,0  
with, 5 
with. 15 
with, 25 
with, 35 
with, 45
with, 10 min post 
without, 0 
without, 5 
without, 15 
without, 25 
without, 35 
without, 45 
without, 10 min post
Count Mean Std. Dev. Std. Error
e 37.065 .607 .214
8 37.136 .543 .192
8 37.444 .458 .162
S 37.662 .455 .161
8 37.833 .421 .149
8 37 965 .479 .169
8 37.736 .922 .326
8 37.065 .560 .198
a 37.189 .481 .170
8 37.514 .416 .147
8 37.744 .446 .158
8 37.923 .472 .167
8 38 038 .464 .164
6 37.653 1.055 .373
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Interaction Plot
Effect: trial * time
Dependent: rectal temp
With Standard Deviation error bars.
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45 10 min post5 15 350 25
time
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 0 vs. Without min 0
df 1
Sum o f  squares -4.44E-16
Mean square -4.44E-I6
F-Value -3.60E-14
P-Value 1.0000
G-G *
H-F *
With min 5 vs. Without min 5
df 1
Sum o f  squares O il
Mean square .011
F-Value .912
P-Value .3450
G-G .2342
H-F .2661
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 15 vs. Without min 15
df 1
Sum o f  squares .020
Mean square .020
F-Value 1.614
P-Value .2109
G-G .1723
H-F .1877
With min 25 vs. Without min 25
df 1
Sum o f  squares .027
Mean square .027
F-Value 2.183
P-Value .1470
G-G .1406
H-F .1481
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 35 vs. Without minSS
df 1
Sum o f  squares .032
Mean square .032
F-Value 2.601
P-Value .1143
G-G .1230
H-F .1264
With min 45 vs. Without min 45
df 1
Sum o f  squares .022
Mean square .022
F-Value 1.766
P-Value .1910
G-G .1627
H-F .1757
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With 10 post vs. Without 10 post
df 1
Sum o f  squares .028
Mean square .028
F-Value 2.237
P-Value .1422
G-G .1381
H-F .1450
With min 0 vs. With min 25
df 1
Sum o f  squares 1.430
Mean square 1.430
F-Value 116.090
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect: Trial * Time
Comparison 10 
Effect: Trial * Time
With min 0 vs. With min 45
df 1
Sum o f  squares 3.240
Mean square 3.240
F-Value 263.026
P-Value .0001
G-G .0001
H-F .0001
With min 45 vs. With 10 post
df 1
Sum o f squares .210
Mean square .210
F-Value 17.041
P-Value .0002
G-G ,0079
H-F .0040
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
51
Comparison 11
Effect: Trial * Time
Comparison 12
Effect: Trial * Time
Without min 0 vs. Without min 25
df 1
Sum o f  squares 1.849
Mean square 1.849
F-Value 150.115
P-Value .0001
G-G .0001
H-F .0001
Without min 0 vs. Without min 45
df 1
Sum o f  squares 3.793
Mean square 3.793
F-Value 307.899
P-Value .0001
G-G .0001
H-F .0001
Comparison 13 
Effect: Trial * Time
Without min 45 vs. Without 10 post
d f 1
Sum o f squares .595
Mean square .595
F-Value 48.341
P-Value .0001
G-G .0003
H-F .0001
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Group 2 RER
Type lit Sum s of Squares
Source df Sum of Squares Mean Square
Dependent: RER
F-Value P-Value G-G H-F
Subject 7 .026 004
Trial 1 .005 .005 3.090 .1222 .1222 .1222
Trial * Subject 7 .011 .002
time 4 -007 -002 3.366 .0227 .0808 .0663
time * Subject 28 .014 .001
Trial * time 4 .002 4.146E-4 4.830 .0043 .0189 .0048
Trial ‘ time * S ... 28 .002 8.583E-5
Means Table 
Effect: Trial 
Dependent: RER
C o u n t M ean S td . D ev. S td . E rro r
with 4 0 .8 9 4 .030 .0 0 5
w ithout 4 0 .9 1 0 .026 .0 0 4
Means Table 
Effect: time 
Dependent: RER
C o u n t M ean S td . D ev. S td . E rror
5  m in 16 .9 1 8 .0 4 5 .011
15 min 16 .9 0 5 .021 .0 0 5
2 5  min 16 .8 9 7 .0 2 2 .006
3 5  m in 16 .9 0 0 .0 2 0 .0 0 5
4 5  m in 16 .8 9 0 .0 2 5 .006
Means Table 
Effect: Trial * time 
Dependent; RER
with. 5 min 
with, 15 min 
with. 25 min 
with. 35 min 
with. 45 min 
without. 5 min 
without. 15 min 
without. 25 min 
without, 35 min 
without. 45 min
Count Mean Std. Dev. Std. Error
8 .903 .044 .015
8 .898 .024 .009
8 .892 .029 .010
8 .899 .023 .008
8 879 .027 .010
8 .932 .045 .016
8 .912 .016 .006
8 .902 .013 .005
8 .901 .018 .006
8 .901 .018 .006
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Interaction Plot 
Effect: Trial * time 
Dependent; RER
With Standard Deviation error bars.
.98
.96 -
.94 -
.92 -’o
I
.88
.86
.84
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Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares .003
Mean square .003
F-Value 39.005
P-Value .0001
G-G .0001
H-F .0001
With min 15 vs. Without min 15
df 1
Sum o f  squares .001
Mean square .001
F-Value 9.439
P-Value .0047
G-G .0138
H-F .0051
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares 3.926E-4
Mean square 3.926E-4
F-Value 4.574
P-Value .0413
G-G .0609
H-F .0427
With min 35 vs. Without min 35
df 1
Sum o f squares 3.008E-5
Mean square 3.008E-5
F-Value .350
P-Value .5586
G-G .4582
H-F .5520
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares .002
Mean square .002
F-Value 21.968
P-Value .0001
G-G .0009
H-F .0001
With min 5 vs. With min 25
df 1
Sum o f  squares 4.893E-4
Mean square 4.893E-4
F-Value 5.701
P-Value .0239
G-G .0471
H-F .0250
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares .002
Mean square .002
F-Value 27.402
P-Value 0001
G-G .0003
H-F .0001
Without min 5 vs. Without min 25
df 1
Sum o f  squares .004
Mean square .004
F-Value 42.178
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares .004
Mean square .004
F-Value 46.147
P-Value .0001
G-G 0001
H-F .0001
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Group 2 HR
Type III Sum s of Squares
Source df Sum of Squares Mean Square
Dependent: HR
F-Value P-Value G-G H-F
Subject 7 6017.780 859,683
Trial 1 3.354 3.354 .007 .9354 .9354 .9354
Trial * Subject 7 3326 857 475.265
time 4 3756.457 939.114 46.169 .0001 .0001 .0001
time * Subject 28 569.541 20.341
Trial * time 4 20.426 5.106 .547 .7025 .6418 .7025
Trial * time * S ... 28 261.277 9331
Means Table 
Effect: Trial 
Dependent: HR
C o u n t M ean S td . D ev. S td . E rro r
with 40 1 5 5 .3 3 7 1 3 .5 1 7 2 .1 3 7
w ithou t 40 1 5 5 .7 4 7 1 3 .2 3 0 2 .0 9 2
Means Table 
Effect: time 
Dependent: HR
C o u n t M ean S td . D ev. S td . E rro r
5  m in 16 1 4 3 .4 1 3 1 4 .5 0 5 3 .6 2 6
15 min 16 1 5 3 .5 1 6 1 1 .7 9 0 2 .9 4 7
2 5  min 16 1 5 7 .1 7 0 1 1 .0 1 7 2 .7 5 4
3 5  m in 16 1 6 0 .7 0 3 9 .9 3 8 2 .4 8 4
4 5  m ln 16 1 6 2 .9 0 9 1 0 .5 0 8 2 .6 2 7
M eans Table 
Effect: Trial * time 
Dependent: HR
with. 5 min 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 5 min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 142.289 14.727 5.207
8 153.229 12.811 4.529
8 157.065 11.083 3.919
8 161.014 9.722 3.437
8 163.090 10.535 3.725
8 144.536 15.202 5.375
8 153.804 11.556 4.086
8 157.275 11.715 4.142
8 160.391 10.811 3.822
8 162.728 11.204 3.961
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Interaction Plot 
Effect: Trial * time 
Dependent: HR
With Standard Deviation error bars.
175
170
165
160
155
135
130
125
5 min 15 min 25 mln 35 min 45 mln
time
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares 20.205
Mean square 20.205
F-Value 2.165
P-Value .1523
G-G .1569
H-F .1523
With min 15 vs. Without min 15
df 1
Sum o f squares 1.323
Mean square 1.323
F-Value .142
P-Value .7094
G-G .6135
H-F .7094
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares .176
Mean square .176
F-Value .019
P-Value .8916
G-G .8048
H-F .8916
With min 35 vs. Without min 35
df 1
Sum o f  squares 1.550
Mean square 1.550
F-Value .166
P-Value .6867
G-G .5926
H-F 6867
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares .526
Mean square .526
F-Value .056
P-Value .8141
G-G .7166
H-F .8141
With min 5 vs. With min 25
df 1
Sum o f  squares 873.350
Mean square 873.350
F-Value 93.593
P-Value .0001
G-G .0001
H-F .0001
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 1730.768
Mean square 1730.768
F-Value 185.479
P-Value .0001
G-G .0001
H-F .0001
Without min 5 vs. Without min 25
df 1
Sum o f  squares 649.103
Mean square 649.103
F-Value 69.562
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares 1323.686
Mean square 1323.686
F-Value 141.854
P-Value .0001
G-G .0001
H-F .0001
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Group 2 Fat utilization
Type III Sum s of Squares
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 393.254 56.179
Trial 1 31.088 31.088 4.591 .0694 .0694 .0694
Trial * Subject 7 47.403 6.772
time 4 38.647 9.662 3.235 .0266 .0927 .0810
time * Subject 28 83.627 2.987
Trial * time 4 6.611 1.653 3.471 .0201 .0443 .0201
Trial * time * S ... 28 13.334 .476
Dependent: Fat oxidation (pmol/kg/min)
Means Table 
Effect: Trial
Dependent: Fat oxidation (pmoi/kg/min)
C o u n t M ean S td . D ev. S td . E rror
with 4 0 7 .8 1 3 2 .8 6 0 .4 5 2
w ithou t 4 0 6 .5 6 6 2 .601 .411
Means Table 
Effect: time
Dependent: Fat oxidation (pmol/kg/min)
C o u n t M ean S td . D ev . S td . E rro r
5  m in 16 6 .0 1 8 4 .091 1 .0 2 3
15  m in 16 6 .9 4 8 2 .5 8 0 .6 4 5
2 5  m in 16 7 .4 8 5 2.461 .6 1 5
3 5  m in 16 7.381 2 .1 4 7 .5 3 7
4 5  m in 16 8 .1 1 8 2 .0 7 4 .5 1 8
Means Table 
Effect: Trial * time
Dependent; Fat oxidation (pmol/kg/min)
with, 5 min 
with. 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 5 min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 7.079 4.152 1.468
8 7.608 2.989 1.057
8 8.010 2.830 1.001
8 7.551 2.309 .816
8 8.819 2.028 .717
8 4.957 4.006 1.416
8 6.289 2.082 .736
8 6.960 2.082 ,736
8 7.210 2.115 .748
8 7.416 1.994 .705
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Interaction Plot 
Effect: Trial * time
Dependent: Fat oxidation (pmol/kg/min) 
With Standard Deviation error bars.
5  10
5 min 15 min 25 min 35 min 45 mln
tim e
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares 17.999
Mean square 17.999
F-Value 37.796
P-Value .0001
G-G .0001
H-F .0001
With min 15 vs. Without min 15
df 1
Sum o f  squares 6.956
Mean square 6.956
F-Value 14.608
P-Value .0007
G-G .0035
H-F .0007
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares 4.410
Mean square 4.410
F-Value 9.261
P-Value .0050
G-G .0137
H-F .0050
With min 35 vs. Without min 35
df 1
Sum o f  squares .466
Mean square .466
F-Value .978
P-Value .3311
G-G .2920
H-F .3311
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares 7.868
Mean square 7.868
F-Value 16.522
P-Value .0004
G-G .0023
H-F .0004
With min 5 vs. With min 25
df 1
Sum o f  squares 3.469
Mean square 3.469
F-Value 7.284
P-Value .0117
G-G .0245
H-F .0117
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 12.110
Mean square 12.110
F-Value 25.431
P-Value .0001
G-G .0004
H-F .0001
Without min 5 vs. Without min 25
df 1
Sum o f squares 16.040
Mean square 16.040
F-Value 33.683
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares 24.182
Mean square 24.182
F-Value 50.780
P-Value .0001
G-G .0001
H-F .0001
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Group 2 CHO
Type III Sum s o f Squares
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 80034.763 11433.538
Trial 1 2405.392 2405.392 3.405 .1075 .1075 .1075
Trial * Subject 7 4944.986 706.427
time 4 2291.994 572.999 1.016 .4159 .3698 .3796
time * Subject 28 15786.211 563.793
Trial * time 4 1973.155 493.289 4.923 ,0039 .0176 .0057
Trial * time * S ... 28 2805.751 100.205
Dependent; CHO oxidation (pmol/kg/min)
Means Table 
Effect; Trial
Dependent: CHO oxidation (pmoi/kg/min)
C o u n t M ean S td . D ev. S td . E rro r
with 4 0 1 7 5 .5 5 8 3 5 .0 4 9 5 .5 4 2
w ithout 40 1 8 6 .5 2 4 3 9 .2 0 0 6 .1 9 8
Means Tabie 
Effect: time
Dependent: CHO oxidation (pmol/kg/min)
C o u n t M ean S td . D ev. S td . E rro r
5 m in 16 1 9 0 .4 9 4 4 8 .5 7 5 1 2 .1 4 4
15 m in 16 1 8 2 .6 2 9 3 0 .9 9 8 7 .7 4 9
2 5  m in 16 175 .2 2 1 3 0 .8 9 9 7 .7 2 5
3 5  min 16 1 7 9 .8 2 2 3 4 .3 2 0 8 .5 8 0
4 5  min 16 1 7 7 .0 3 9 4 1 .7 5 8 1 0 .4 3 9
Means Table 
Effect: Trial * time
Dependent; CHO oxidation (pmol/kg/min)
with, 5 min 
with. 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 5  min 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 176.470 43.580 15.408
8 177.061 28.832 10.194
8 172.626 31.488 11.133
8 180.784 34,889 12.335
8 170,848 42.836 15.145
8 204.518 52.032 18.396
8 188.197 34.012 12.025
8 177.816 32.233 11.396
8 178.861 36.120 12.770
8 183.230 42.592 15.058
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Interaction Plot 
Effect: Trial * time
Dependent: CHO oxidation (pmol/kg/min) 
Witti Standard Deviation error bars.
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Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares 3146.649
Mean square 3146.649
F-Value 31.402
P-Value .0001
G-G .0002
H-F .0001
With min 15 vs. Without min 15
df 1
Sum o f squares 496.064
Mean square 496.064
F-Value 4.950
P-Value 0343
G-G .0552
H-F .0389
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares 107.744
Mean square 107.744
F-Value 1.075
P-Value .3086
G-G .2688
H-F .3009
With min 35 vs. Without min 35
df 1
Sum o f squares 14.784
Mean square 14.784
F-Value .148
P-Value .7038
G-G .5657
H-F .6752
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
63
Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares 613.305
Mean square 613.305
F-Value 6.120
P-Value .0197
G-G .0381
H-F .0234
With min 5 vs. With min 25
df 1
Sum o f  squares 59.098
Mean square 59.098
F-Value .590
P-Value .4489
G-G .3677
H-F .4317
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 126.450
Mean square 126.450
F-Value 1.262
P-Value .2708
G-G .2423
H-F .2657
Without min 5 vs. Without min 25
df 1
Sum o f  squares 2851.827
Mean square 2851.827
F-Value 28.460
P-Value .0001
G-G .0004
H-F .0001
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares 1812.631
Mean square 1812.631
F-Value 18.089
P-Value .0002
G-G .0022
H-F .0004
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Group 2 RPE
Type III Sum s of Squares
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 108.122 15.446
Trial 1 2.278 2.278 .617 ,4579 .4579 .4579
Trial * Subject 7 25.847 3.692
time 4 94.331 23.583 23.154 .0001 .0007 .0004
time * Subject 28 28.519 1.019
Trial * time 4 1.269 .317 .539 .7084 .5502 .5811
Trial * time * S ... 28 16.481 .589
Dependent: RPE
Means Table 
Effect: Trial 
Dependent: RPE
C o u n t M ean S td . D ev. S td . E rro r
with 40 1 3 .2 2 5 1 .8 7 4 ,2 9 6
w ithou t 40 1 3 .5 6 2 1 .8 7 8 .2 9 7
Means Table 
Effect: time 
Dependent: RPE
C o u n t M ean S td . D ev . S td . E rror
5  m in 16 11 .781 1 .3 0 3 .3 2 6
15  m in 16 1 2 .5 9 4 1 .1 4 3 .2 8 6
2 5  m in 16 1 3 .5 6 2 1 .4 2 4 .356
3 5  m in 16 14.281 1 .6 7 3 .4 1 8
4 5  m in 16 1 4 .7 5 0 2 .0 8 2 .5 2 0
Means Table 
Effect: Trial * time 
Dependent: RPE
with, 5 min 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 5 min 
without, 15 min 
without, 25 mln 
without, 35 min 
without, 45 min
Count Mean Std. Dev. Std. Error
8 11.688 1.335 .472
8 12.312 .884 .312
8 13.562 1.237 .438
8 13.938 1.935 .684
8 14.625 2.264 .800
8 11.875 1.356 .479
8 12.875 1.356 .479
8 13.562 1.678 .593
8 14.625 1.408 .498
8 14.875 2.031 .718
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Interaction Plot 
Effect: Trial * time 
Dependent: RPE
With Standard Deviation error bars.
16
15
10
15 min 25 min 35 min5 min 45 mln
time
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares .141
Mean square .141
F-Value .239
P-Value .6288
G-G .4082
H-F .4494
With min 15 vs. Without min 15
df 1
Sum o f squares 1.266
Mean square 1.266
F-Value 2.150
P-Value .1537
G-G .1508
H-F .1548
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares .0000
Mean square .0000
F-Value .0000
P-Value 1.000
G-G 1.000
H-F 1.000
With min 35 vs. Without min 35
df 1
Sum o f  squares 1.891
Mean square 1.891
F-Value 3.212
P-Value .0839
G-G .1075
H-F .1061
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect; Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares .250
Mean square .250
F-Value .425
P-Value .5199
G-G .3440
H-F .3767
With min 5 vs. With min 25
df 1
Sum o f  squares 14.062
Mean square 14.062
F-Value 23.891
P-Value .0001
G-G .0033
H-F .0019
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 34.516
Mean square 34.516
F-Value 58.639
P-Value .0001
G-G .0002
H-F .0001
Without min 5 vs. Without min 25
df 1
Sum o f  squares 11.391
Mean square 11.391
F-Value 19.352
P-Value .0001
G-G .0058
H-F .0036
Comparison 9 
Effect; Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares 36.000
Mean square 36.000
F-Value 31.160
P-Value .0001
G-G .0001
H-F .0001
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Group 2 Lactate
Type III Sum s of Squares
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 140.934 20.133
Trial 1 .913 .913 .398 .5480 .5480 .5480
Trial * Subject 7 16.050 2.293
time 4 36.539 9.135 7,256 .0004 .0047 ,0009
time * Subject 28 35.252 1.259
Trial * time 4 1 311 .328 .646 .6342 .5515 .6046
Trial * time * S ... 28 14.206 .507
Dependent; lactate (mM)
Means Table 
Effect: Trial
Dependent: lactate (mM)
C o u n t M ean S td . D ev . S td . E rror
with 4 0 3 .4 4 2 1 .6 2 6 .257
w ithout 4 0 3 .6 5 6 1 .9 0 3 .301
Means Table 
Effect: time
Dependent: lactate (mM)
C o u n t M ean S td . D ev. S td . E rro r
0  m in 16 2 .2 5 7 1 .0 3 3 .2 5 8
15 m in 16 3 .5 1 0 1 .8 7 0 .467
2 5  m in 16 3 .8 7 4 1 .8 0 5 .451
3 5  m in 16 4 .0 7 0 1 .6 8 8 .422
4 5  m in 16 4 .0 3 5 1.801 .4 5 0
Means Table 
Effect: Trial * time 
Dependent: lactate (mM)
with, 0  mln 
with, 15 min 
with, 25 min 
with, 35 min 
with, 45 min 
without, 0 mln 
without, 15 min 
without, 25 min 
without, 35 min 
without, 45 mln
Count Mean Std. Dev. Std. Error
8 2.247 1.062 .375
8 3.438 1.856 .656
8 3.929 1.690 .598
8 3.850 1.542 .545
8 3.748 1.649 .583
6 2.267 1.076 .381
8 3.583 2.008 .710
8 3.819 2.029 .717
8 4.290 1.902 .672
8 4.321 2.010 .711
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
68
I
I
Is
Interaction Plot 
Effect: Trial * time 
Dependent: lactate (mM)
With Standard Deviation error bars.
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15 min 25 min 35 min 45 min0 min
time
Comparison 1 
Effect; Trial * Time
Comparison 2 
Effect: Trial * Time
With min 5 vs. Without min 5
df 1
Sum o f  squares .002
Mean square .002
F-Value .003
P-Value .9567
G-G .8441
H-F .9263
With min 15 vs. Without min 15
df 1
Sum o f  squares .085
Mean square .085
F-Value .167
P-Value .6862
G-G .5352
H-F .6328
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 25 vs. Without min 25
df 1
Sum o f  squares .048
Mean square .048
F-Value .095
P-Value .7597
G-G .5994
H-F 1 .7045
With min 35 vs. Without min 35
df 1
Sum o f  squares .774
Mean square .774
F-Value 1.526
P-Value .2269
G-G .2087
H-F .2222
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 45 vs. Without min45
df 1
Sum o f  squares 1.316
Mean square 1.316
F-Value 2.593
P-Value .1185
G-G .1310
H-F .1250
With min 5 vs. With min 25
df 1
Sum o f  squares 11.308
Mean square 11.308
F-Value 22.289
P-Value .0001
G-G .0013
H-F .0002
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With min 5 vs. With min 45
df 1
Sum o f  squares 9.008
Mean square 9.008
F-Value 17.754
P-Value .0002
G-G .0028
H-F .0007
Without min 5 vs. Without min 25
df 1
Sum o f  squares 9.633
Mean square 9.633
F-Value 18.987
P-Value .0002
G-G .0022
H-F .0005
Comparison 9 
Effect: Trial * Time
Without min 5 vs. Without min 45
df 1
Sum o f  squares 16.886
Mean square 16.886
F-Value 33.283
P-Value .0001
G-G .0002
H-F .0001
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Group 2 Temperature
T ype III S u m s  o f  S q u a re s
Source df Sum of Squares Mean Square F-Value P-Value G-G H-F
Subject 7 18281 2612
trial 1 .029 .029 .032 .8628 .8628 .8628
trial * Subject 7 6.405 .915
time 6 47.198 7.866 168.904 .0001 .0001 .0001
time * Subject 42 1.956 .047
trial * time 6 -100 .017 .397 .8766 .6714 7312
trial *time * S ... 42 1.763 .042
Dependent: rectal temp
Means Table 
Effect: trial
Dependent: rectal temp
C o u n t M ean S td . D ev. S td . E rro r
with 56 3 7 .9 7 9 .8 4 4 .1 1 3
wnthout 56 3 8 .0 1 1 .814 .1 0 9
Means Table 
Effect: time
Dependent: rectal temp
0
5
15
2 5
3 5
4 5
10 m ln p o s t
Count M ean S td . D ev . S td . E rror
16 3 7 .0 3 8 .4 9 8 .1 2 4
16 3 7 .1 7 0 .487 .1 2 2
16 3 7 .7 1 1 .4 8 4 .121
16 3 8 .1 6 2 .5 1 6 .1 2 9
16 3 8 .4 9 6 .5 4 2 .1 3 5
16 38 .781 .6 0 5 .151
16 3 8 .6 0 8 .507 .1 2 7
Means Table 
Effect: trial * time 
Dependent: rectal temp
with, 0 
with, 5 
with, 15 
with, 25 
with, 35 
with, 45
with, 10 min post 
without, 0 
without, 5 
without, 15 
without, 25 
without, 35 
without, 45 
without, 10 min post
Count Mean Std. Dev. Std, Error
S 37.054 .490 ,173
8 37.172 .511 .181
8 37.688 .511 .181
8 38.130 .582 .206
8 38.489 .645 .228
8 38.789 .718 .254
8 38.529 .578 .204
8 37.021 .539 .191
8 37.168 .498 .176
8 37.734 .489 .173
8 38.194 .479 .170
8 38.504 .462 .163
8 38.773 .519 .184
8 38.686 .449 .159
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Interaction Plot
Effect: trial * time
Dependent: rectal temp
With Standard Deviation error bars.
4 0
39.5
39 -
38.5
38
3 7 .5
37 -
36.5 -
36
1 5 25 35 45 10 mln post
tim e
Comparison 1 
Effect: Trial * Time
Comparison 2 
Effect: Trial * Time
With min 0 vs. Without min 0
df 1
Sum o f  squares .004
Mean square .004
F-Value .103
P-Value .7495
G-G .4488
H-F .5285
With min 5 vs. Without min 5
df 1
Sum o f  squares 8.100E-5
Mean square 8.100E-5
F-Value .002
P-Value .9652
G-G .7075
H-F .8018
Comparison 3 
Effect: Trial * Time
Comparison 4 
Effect: Trial * Time
With min 15 vs. Without min 15
df 1
Sum o f  squares .008
Mean square .008
F-Value .195
P-Value .6609
G-G .3910
H-F .4601
With min 25 vs. Without min 25
df 1
Sum o f  squares .016
Mean square .016
F-Value .381
P-Value .5403
G-G .3250
H-F .3795
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Comparison 5
Effect: Trial * Time
Comparison 6
Effect: Trial * Time
With min 35 vs. Without min 35
df 1
Sum o f  squares .001
Mean square .001
F-Value .021
P-Value .8862
G-G .5727
H-F .6670
With min 45 vs. Without min 45
df 1
Sum o f  squares .001
Mean square .001
F-Value .025
P-Value .8747
G-G .5593
H-F .6527
Comparison 7 
Effect: Trial * Time
Comparison 8 
Effect: Trial * Time
With 10 post vs. Without 10 post
df 1
Sum o f  squares .099
Mean square .099
F-Value 2.357
P-Value .1322
G-G .1325
H-F .1382
With min 0 vs. With min 25
df 1
Sum o f  squares 4.634
Mean square 4.634
F-Value 110.411
P-Value .0001
G-G .0001
H-F .0001
Comparison 9 
Effect: Trial * Time
Comparison 10 
Effect: Trial * Time
With min 0 vs. With min 45
df 1
Sum o f  squares 12.035
Mean square 12.035
F-Value 286.755
P-Value .0001
G-G .0001
H-F .0001
With min 45 vs. With 10 post
df 1
Sum o f squares .270
Mean square .270
F-Value 6.430
P-Value .0150
G-G .0477
H-F .0400
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Comparison 11
Effect: Trial * Time
Comparison 12
Effect: Trial * Time
Without min 0 vs. Without min 25
df 1
Sum o f  squares 5.499
Mean square 5.499
F-Value 131.023
P-Value .0001
G-G .0001
H-F .0001
Without min 0 vs. Without min 45
df 1
Sum o f  squares 12.268
Mean square 12.268
F-Value 292.292
P-Value .0001
G-G .0001
H-F .0001
Comparison 13 
Effect: Trial * Time
Without min 45 vs. Without 10 
post
df 1
Sum o f  squares .030
Mean square .0303
F-Value .709
P-Value .4045
G-G .2599
H-F .2981
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Abstract
Purpose: To examine the effects of peripheral cooling via the rapid thermal exchange 
(RTX) cooling device (AVAcore Technologies Inc.) on whole body substrate oxidation 
during exercise at a moderate ambient temperature (28°C). Methods: Subjects (N=16) 
completed two 45-minute cycle ergometer trials at 90% of ventilatory threshold (VT) 
with RTX peripheral cooling and without (CON). Rectal temperature was continuously 
recorded throughout both trials. VO2 and VCO2 were monitored to compute whole body 
substrate oxidation. Significance was set at p < 0.05. Results: Despite no differences in 
rectal temperature between trials, mean CHO oxidation was lower during RTX (1453 ± 
299 kj) versus CON (1546 ±291 kJ). Conversely, mean fat oxidation was higher during 
RTX (719 ± 248 kJ) versus CON (610 ± 197 kJ). HR and RPE were similar between 
trials. Conclusion: These data indicate the RTX device promotes a decrease in whole 
body carbohydrate (CHO) reliance despite no difference in rectal temperature. Supported 
by AVAcore Technologies, Inc.
Key words: Carbohydrate, fat, AVAcore.
Running Head: Effects of Peripheral Cooling on Substrate Selection.
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Introduction
It has been recognized that a rise in body temperature during submaximal exercise 
will increase muscle glycogenolysis during exercise [1,2,3]- Previous research has shown 
that an attenuated rise in body temperature either by reducing ambient temperatures [2,4], 
or by cooling [5,6] will reduce temperature induced increases in glycogen flux and total 
carbohydrate oxidation.
Heat stress also influences lipid mobilization and oxidation, although the 
concentration o f plasma free fatty acids are unaffected by heat stress [3]. Additionally, it 
has been shown that intramuscular triacylglycerol utilization [3] and free fatty acid 
uptake [7] are reduced under conditions of muscular thermal stress. These data may 
suggest a reduction in free fatty acid release by adipocytes during exercise in the heat [8]. 
It has also been suggested that elevated muscle temperature decreases phosphorylative 
efficiency in isolated skeletal muscle mitochondria, increasing the reliance on 
carbohydrate as the primary substrate [9]. Febbraio [1] suggests that elevated muscle 
temperature may impair mitochondrial function. Mills et al. [10] observed an increase of 
lipid peroxides, an indicator o f oxidative stress, in the plasma of hyperthermic horses 
exercising to fatigue, possibly supporting the notion that heat stress may impair metabolic 
function.
To examine alterations in substrate oxidation in the heat, previous research has 
utilized the measurement techniques of indirect calorimetry [4,11], rates of glucose 
disposal (glucose Rd) [11], and muscle glycogen depletion [4,6]. It has been shown that 
heat stress stimulates an increase in hepatic glucose production (glucose Ra) without a 
concomitant rise in glucose Rd [11]. Febbraio [1] suggests that an increase in body
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temperature and perceived effort promote a feed-forward effect resulting in increased 
blood catecholamines which in return increases muscle glycogenonlysis.
Past research has consistently demonstrated increased whole body CHO oxidation 
from indirect calorimetry during heat stress [4,11,12]. Augmented glycogen utilization 
during heat stress was first reported by Fink et al. [3] while comparing exercise at 
ambient temperatures of 40”C and 9°C. Fink et al. also noted an increased respiratory 
exchange ratio and reduced intramuscular triglyceride use. Using water-perfused cuffs to 
cool one thigh and heat the other during submaximal exercise, Starkie et al. [6] found 
lower post exercise muscle glycogen levels in the heated leg compared with the cool leg.
Consistent with increased CHO oxidation, previous studies have consistently 
demonstrated an elevated blood lactate accumulation during exercise in the heat 
[3,4,11,12]. Hargreaves et al. [11] suggests that increased blood lactate is associated with 
increased rates o f muscle glycogenolysis, since total carbohydrate oxidation is increased 
while glucose Rd is unaltered.
Past research on substrate use under conditions o f heat stress can be categorized 
into two parts: 1) those comparing exercise in extremely different ambient temperatures 
or 2) those comparing exercise using cooling methods resulting in temperatures 
exceedingly lower than normal ambient working temperatures. Under normal 
circumstances exercise is most often performed within a relatively narrow temperature 
range o f comfortable temperatures unlike the extreme temperature differences used for 
most prior research.
Slight to moderate core temperature cooling can be achieved through use o f the 
AVAcore (AVAcore Technologies Inc.) rapid thermal exchange (called RTX) device.
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The technology behind the RTX exploits the fact that under various surfaces of the body 
are arterio-venous anastomoses and venous plexuses involved in heat exchange from the 
body to the environment. These special exchange sites are found in high concentrations 
on the palms o f the hands, soles of the feet and on the face. Blood flow is amplified to 
these areas with the AVAcore RTX device by using negative pressure to enhance heat 
exchange. The RTX’s temperature is controlled via water flow at adjustable 
temperatures, which cools a metal surface on which the palm o f the hand is placed.
The purpose of this study was therefore to evaluate the effect of exercise on 
substrate utilization at ambient temperatures commonly found in exercise facilities 
(28”C). We compared substrate utilization under conditions of slight cooling (22°C) of 
one hand using the RTX with negative pressure to a control trial (CON) without cooling. 
We hypothesized that the RTX cooling device would significantly reduce body 
temperature during exercise thereby reducing calculated rates of whole body CHO 
oxidation.
Methods
Sixteen recreationally active males participated in the study after completing a 
University IRB approved informed consent.
Exercise Testing
For the initial session subjects completed a graded exercise cycle test using a 
Monark 824E mechanically braked cycle ergometer (Varberg, Sweden) to determine 
ventilatory threshold (VT) and peak VO2 work rates. The graded exercise consisted o f 1- 
minute (min) stages starting at 70-watts and increased 15-watts for each subsequent stage
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until volitional exhaustion. Cadence was maintained at 70 revolutions per minute. 
Expired gases were collected using a calibrated metabolic cart (Parvomedics, Inc., Salt 
Lake City, UT) and analyzed at 15-second intervals. VT was determined using a 
combination of the V-slope method, the ventilatory equivalent method and the excess 
CO2 method [13]. Subject’s characteristics are outlined in Table 1.
Trials
Each subject was asked to refrain from strenuous exercise, caffeine, alcohol, and 
tobacco for 24-hours prior to each trial. All trials were performed in the morning 
following a 10-hour fast. Subjects cycled at an intensity equivalent to 90% of VT work 
rate for 45-min. Exercise chamber temperature was controlled at 28"C for both trials. 
Subjects received either 22*̂ C cooling (RTX) from the AVAcore hand device (manifold 
T= 22®C, P=635mmHg) or no cooling (control=CON) using a random cross-over design. 
Core body temperature was continuously recorded on an Omega data logger using a 
Mon-a-therm (Mallinkrodt Medical, Inc.) rectal probe inserted to a depth of at least 10 
cm. Heart rate was monitored with a telemetry system (Polar, Port Washington, NY) and 
recorded using a 2-min average every 10-min, starting at min 5. RPE was recorded every 
10-min starting at min 5.
Whole blood samples (15pl) to measure blood lactate were collected from the 
fingertip at min 0, 15, 25, 35 and 45. Blood samples were mixed with 100 p.1 chilled 
perchloric acid and stored at -30“C until subsequent analysis. Blood lactate was analyzed 
using an enzymatic, spectrophotometric method. All samples were analyzed in duplicate.
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Whole body carbohydrate and fat oxidation were calculated, using the Frayn 
equation [14], from average steady state VO2 and VCO2 measures collected for the 2-min 
prior to min 5, 15, 25, 35 and 45 of the trial. Following the completion of each trial, a 
passive recovery took place for 10-min in which time only rectal temperature was 
recorded.
Statistics
HR, RPE, fat oxidation (pmol*kg ’*min'*) and CHO oxidation (pmol.kg '.min'^) 
were compared across trials using apriori planned comparison for min 5, 15, 25, 35, and 
45. Pre-planned comparisons were used to examine within trials differences in HR, RPE, 
fat oxidation and CHO oxidation at min 5 vs. 45. Temperature differences between trials 
were examined using apriori planned comparisons at min 0, 45, and 10-min post exercise. 
Apriori planned comparisons were also used to determine within trial changes in 
temperature (min 0 vs. 45 and min 45 vs. 10-min post). Differences in overall energy 
expenditure (total kJ), total fat kJ (fat kJ), and total CHO kJ (CHO kJ), were examined 
using 2-tailed paired t-tests. Blood lactate was examined using apriori planned 
comparisons between trials at min 15, 25, 35, and 45 and within trials across time (min 0 
vs. 45). Statistical significance was set at p < 0.05. All data are shown as means ± 
standard deviation (SD).
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Results 
CHO Utilization
Within trials both RTX and CON demonstrated significant decreases in CHO 
oxidation with time from min 5 to 45 (RTX ACHO = -6.5 ±17.1 nmol*kg‘̂ *min *, p <
0.05, CON ACHO = -22.5 ± 26.5 pmol«kg’^«min'*, p < 0.001). Between trials CHO 
oxidation was significantly decreased during RTX compared with CON at min 5, 15, 25, 
and 45 (see Figure 1).
Fat Utilization
Within trials both RTX and CON demonstrated significant increases in fat 
oxidation from min 5 to 45 (RTX AFAT = 1.5 ± 2.4 pmol.kg'^.min'\ p < 0.001, CON 
AFAT = 2.4 ±1.7  pmol.kg"^.min'% p < 0.001). Between trials RTX cooling resulted in a 
significant decrease in fat utilization at min 5, 15, 25 and 45 compared with CON (see 
Figure 2).
Heart Rate
Within trials heart rate increased significantly with time between min 0 and 45 for 
both trials (RTX AHR = 21.6 ± 7.4, p < 0.001, CONAHR = 18.3 ± 8.3, p < 0.001). 
Between trials, RTX resulted in a significantly lower heart rate only at min 5 compared to 
CON (p < 0.01, see Table 2).
RPE
Within trials there was a significant increased in RPE between min 0 and 45 for 
both trials (RTX ARPE = 2.3 ± 2.1, p < 0.001, CON ARPE = 3.2 ± 2.4, p < 0.001). RPE
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during RTX cooling was significantly lower at min 15 (p < 0.05) and 35 (p < 0.05) 
compared with CON (see Table 2).
Rectal Temperature
There were no significant differences in rectal temperature between trials (see 
Figure 3). Both trials resulted in a significant increase in rectal temperature between min 
0 and 45 (RTX A'̂ C = 1.3 ± 0.6, p<0.001, CON A°C = 1.4 ± 0.5, p < 0.001), and a 
significant decrease between min 45 and 10-min post (RTX A°C = -0.2 ±0.5, p<0.001, 
CON A°C = -0.2 ± 0.6, p < 0.001).
Blood Lactate
Both trials resulted in a significant increase in blood lactate (BLa^) with time 
between min 5 and 45 (RTX ABLa^ = 1.1± I .l mM, p<0.001, CON A BLa^ = 2.1 ± 2.4 
mM, p < 0.001). During RTX, BLa^ was significantly lower at min 35 (p < 0.05) and 45 
(p < 0.001) compared with CON (see Table 3).
Energy Expenditure
Total energy expenditure was not significantly different between trials 
(RTX-2172 ± 426 kJ, CON=2156 ± 403 kJ, p = 0.31). RTX resulted in both greater total 
fat utilization than CON (719 ± 248 kJ vs. 610 ± 197 kJ respectively, p<0.01) and lower 
total CHO utilization (1453 ± 299 kJ vs. 1546 ±291 kJ respectively, p<0.05) than CON 
(see Table 4).
Discussion
Previous studies have shown that cooling influences metabolic substrate selection 
during exercise [1,2,3,7]. Febbraio [8] suggests that changes in body temperature greater
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
83
than 0.4®C can cause decreased fat and increased carbohydrate metabolism. The present 
study differed from the results of Febbraio in that RTX hand cooling resulting in 
decreased CHO and increased fat utilization despite no significant differences in rectal 
temperature between trials. During the cooling trial with the AVAcore RTX device, the 
decreased reliance on CHO and increased reliance on fat occurred largely at the 
beginning of exercise (min 5 = 5.2 ± 3.6 vs. 3.5 ± 3.2 pmohkg'^min ' for RTX and CON 
respectively). We cannot explain the physiological mechanism responsible for this early 
decreased reliance in CHO. Some psychological or other feedback mechanism as a result 
of the hand on the cool surface of the RTX may have influenced catecholamine response 
early in the exercise, which was later modulated by the effects of the exercise. We have 
no evidence for these effects, but the pattern of reduced CHO dependence during early 
exercise in the RTX trial was seen across subjects.
Hargreaves and colleagues [11] suggest that during heat stress an increased blood 
lactate may be associated with an increased rate of muscle glycogenolysis, since blood 
glucose uptake is reduced with a concomitant rise in total carbohydrate oxidation. The 
present data demonstrates an increase in blood lactate during the last 10-min of exercise 
in the CON. Considering the difference in CHO oxidation across trials at the end of 
exercise, these results suggest a possible increase in muscle glycogenolysis during the 
later portion of CON. However, we are skeptical to conclude that glucose uptake was 
altered due to an increased heat load during the CON trial as there were no differences in 
rectal temperature. The subtle cooling provided by the RTX may have had other effects 
than cooling core temperature. An additional possibility is that the temperature in the 
working skeletal muscle was reduced due to increased perfusion of slightly cooled blood.
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while the rectal temperature remained unaffected due to reduced blood flow to the gut 
during exercise.
At exercise intensities below VT it is common to note an increased reliance on fat 
oxidation over time. Given the mild temperature environment and the moderate exercise 
intensity of the present study, it is doubtful that muscle temperature increased to a level 
that would impair lipid metabolism through oxidative phosphorylation [9]. During the 
first 15 minutes of exercise the core temperature under both trials was less than 37.6 C 
and peak core temperature averaged near 38.4°C at the end of exercise. Why there would 
be a difference in substrate utilization at the lower temperatures early in exercise and no 
difference at the moderate core temperature after 45 minutes of exercise cannot be 
explained by previous research. Our data agree with others that there should be no 
difference during the later stages o f exercise when core temperature values were not 
different, however the early differences do not appear to be a result of changes in core 
temperature. Although catecholamines have been shown to alter substrate selection and 
are increased during heat stress [2,11,15], it is unclear whether variations in epinephrine 
could explain the observed difference in substrate oxidation since we did not measure 
catecholamine levels in the present study. CON resulted in a significantly higher RPE at 
min 15 and 35, and approached significance at min 25 (p = 0.09) and 45 (p = 0.07).
This may suggest an increase in sympathetic drive, which would stimulate both hepatic 
glucose production and carbohydrate oxidation [8]. However, increased catecholamines 
should also cause an increase in HR, and there were no differences in the HR response 
between trials with the exception of the initial 5 minutes (RTX 131 ± 17, CON 134 ± 17). 
The decreased HR at min 5, combined with the lower CHO oxidation early in the RTX
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trial possibly suggest that there was some reduction of catecholamines due to the cooling 
device though this possibility will require further study.
The similar total energy expenditure between trials verifies the similarity in 
exercise intensity across trials (see Table 4). That there were no differences in core 
temperature, no differences in energy expenditure yet early differences in HR and 
substrate utilization suggest some effect of the RTX device that is not linked to core 
temperature changes in this study. Use of the RTX may suppress muscle glycogenolysis 
during the early portion of an exercise session with continued small glycogen sparing 
over the course of the submaximal exercise bout. For long slow distance (low intensity) 
aerobic exercise sessions, or to enhance recovery between exercise sessions by reducing 
within session glycogen depletion, the RTX device may provide benefits to athletes if 
mobile units are developed.
Conclusion
In summary, the findings o f our study suggest that the use o f the AVAcore RTX 
to supply peripheral cooling influences substrate selection during exercise near VT, 
especially within the initial stages of an exercise session. However, the underlying 
physiological mechanism(s) for these results are unclear as there were no rectal 
temperature differences between trials.
Future research should incorporate measures of intramuscular temperature, 
patterns of muscle glycogen depletion, and substrate kinetics to further evaluate the 
physiological effects of the RTX device during exercise.
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Table 1. Descriptive characteristics of subjects (mean ± SD)
Subject (N=16)
Age (yr) 25.5 ± 6 .0
Height (in) 70.4 ± 2.2
Height (cm) 178.9 ± 5.7
Body Weight (kg) 85.7 ±21.6
Fat Mass (kg) 14.6 ± 14.4
Fat Free Mass (kg) 71.1 ± 8.3
PeakVOz (L-min*) 
PeakVOz (ml«kg'*»min'*)
3.9 ± 0.5
48.9 ± 14.5
VT (L.min )̂
VT (ml-kg’’ •min'*)
2.5 ±0.5
31.6± 11.3
VT (%V02peak) 64.0 ± 5.4%
Peak VO2 = peak oxygen uptake; VT = ventilatory threshold.
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Table 2. Heart rate and rate of perceived exertion with RTX and CON.
Minute 5 15 25 35 45
HR
RTX 131± 17* 141 ± 18 146 ± 17 151 ± 16 153 ± 16̂ ^
CON 135 ± 17 142 ± 18 146 ± 17 150± 16 153 ± 16̂ ^
RPE
RTX 11.5 d: 1.3 12.4 ± 1.0* 13.3 ±1.2 14.0 ± 1.8* 14.4 ± 2.0^
CON 11.7± 1.2 12.9 ± 1.4 13.7 ±1.7 14.5 ± 1.6 14.8 ±2.1^
Significant difference between RTX and CON *p < 0.05 .
Significant difference between minute 5 and 45 within trials #p < 0.05.
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Table 3. Comparison o f Blood Lactate (mM) between RTX and CON.
Minute 0 15 25 35 45
RTX 2.3 ± .9 3.5 ± 1.5 3.8 ± 1.4 3.9 ± 1.5* 3.5 ± 1.3*"
CON 2.4 ± 1.1 3.8 ± 1.8 3.8 ± 1.7 4.5 ± 2.0 4.5 ±2.5^
*p < 0.05 Significant difference between RTX and CON.
iip < 0.05 Significant difference between minute 0 and 45 within trials.
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Table 4. Exercise trial data. The intensity of exercise is shown both as a percent of 
VOzmax (% VOzmax) and as a percent of VOzvt (%VT). Total substrate oxidation in 
kilojoules for the 45 minutes of exercise is shown for carbohydrate (CHO kJ), fat (FAT 
kJ) and overall (Total kJ).
Trial %VOz max %VT CHOkJ Fat kJ Total kJ
RTX
CON
60.8 ± .07 
59.2 ± .06
94.0 ± .07
93.1 ± .06
1453 dz 299* 
1546 ±291
719 ±248* 
610± 197
2172 ±426 
2156 ±403
*p < 0.05 Significant difference vs. CON.
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Figures Legend
Figure 1. CHO oxidation o f subjects during RTX and CON (Mean ± SE),
*p < 0.05 RTX vs. CON.
#p < 0.05. vs. min 0 within trials.
Figure 2. Fat oxidation o f subjects during RTX and CON (Mean ± SE).
*p < 0.05 RTX vs. CON.
#p < 0.05. vs. min 0 within trials.
Figure 3. Rectal temperature of subjects during RTX and CON (Mean ± SE). There 
were no significant differences between trials.
#p < 0.05 min 0 vs. 45 within trials, 
tp  < 0.05 min 45 vs. 10-post within trials.
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